,Paper,Ref,Serum/Plasma,#Subjects,Healthy/Unhealthy,Fasted/Fed,Analysis Technique,Units,CA,CDCA,DCA,UDCA,LCA,G-CA,G-CDCA,G-DCA,G-UDCA,G-LCA,T-CA,T-CDCA,T-DCA,T-UDCA,T-LCA,totalCA,totalCDCA,totalDCA,totalUDCA,totalLCA,Conjugated:Unconjugated,2nd:1st,Disease,Biliary/Hepato,Liver/Non-liver,NAFLD/NASH/Cirrhosis,Metabolic/HCC/Cholestatsis,Males,Females,Average Age,Extraction,Starting Volume,Protein Precipitation,Evaporation Technique,Reconstitution Solvent,Extraction Method,Derivitisation,Exact Analysis Technique,Publication Year,Value Type,Total Bilirubin (mg/dL),NOTES,Number of Patients
0,Altered Bile Acid Metabolome in Patients with Nonalcoholic Steatohepatitis,https://doi.org/10.1007/s10620-015-3776-8,Serum,7,Unhealthy,Fed,LC-MS,nM,237.0,359.0,441.0,,20.9,417.0,1917.0,1038.0,387.0,53.8,236.0,384.0,268.0,25.4,16.9,890.0,2660.0,1747.0,,91.6,4.483505057,0.634084507,NASH,,Liver,NASH,Metabolic,3.0,4.0,48.0,50ul serum. 150ul MeOH with IS. Vortex. Stand for 10min. Centrifuge. 160ul SN vacuum-dried. Reconstituted in equal volumes acetonitrile H2O. ,50.0,Methanol,Vacuum,Acetonitrile:H2O,,,UPLC-TQMS,2015,Arithmetic Mean,0.81,UPLC-TQMS: NASH Post-Prandial 30 mins,7.0
1,Altered Bile Acid Metabolome in Patients with Nonalcoholic Steatohepatitis,https://doi.org/10.1007/s10620-015-3776-8,Serum,15,Normal,Fed,LC-MS,nM,142.0,135.9,261.0,,15.0,234.0,54.5,402.0,109.0,61.2,67.1,141.0,904.0,3.8,3.5,443.1,331.4,1567.0,,79.7,3.574833002,2.27178825,,,Healthy,Normal,Normal,7.0,8.0,,50ul serum. 150ul MeOH with IS. Vortex. Stand for 10min. Centrifuge. 160ul SN vacuum-dried. Reconstituted in equal volumes acetonitrile H2O. ,50.0,Methanol,Vacuum,Acetonitrile:H2O,,,UPLC-TQMS,2015,Arithmetic Mean,0.63,UPLC-TQMS: Healthy Post-Prandial 60 mins,15.0
2,Altered Bile Acid Metabolome in Patients with Nonalcoholic Steatohepatitis,https://doi.org/10.1007/s10620-015-3776-8,Serum,15,Normal,Fed,LC-MS,nM,184.0,119.0,262.0,,19.6,228.0,923.0,389.0,101.0,53.5,67.3,140.0,96.7,3.8,4.0,479.3,1182.0,747.7,,77.1,3.431919261,0.559561789,,,Healthy,Normal,Normal,7.0,8.0,,50ul serum. 150ul MeOH with IS. Vortex. Stand for 10min. Centrifuge. 160ul SN vacuum-dried. Reconstituted in equal volumes acetonitrile H2O. ,50.0,Methanol,Vacuum,Acetonitrile:H2O,,,UPLC-TQMS,2015,Arithmetic Mean,0.63,UPLC-TQMS: Healthy Post-Prandial 30 mins,15.0
3,Altered Bile Acid Metabolome in Patients with Nonalcoholic Steatohepatitis,https://doi.org/10.1007/s10620-015-3776-8,Serum,7,Unhealthy,Fed,LC-MS,nM,166.0,325.0,447.0,,20.0,432.0,129.0,926.0,335.0,43.4,239.0,372.0,283.0,18.1,15.1,837.0,826.0,1656.0,,78.5,2.915031315,1.255321708,NASH,,Liver,NASH,Metabolic,3.0,4.0,48.0,50ul serum. 150ul MeOH with IS. Vortex. Stand for 10min. Centrifuge. 160ul SN vacuum-dried. Reconstituted in equal volumes acetonitrile H2O. ,50.0,Methanol,Vacuum,Acetonitrile:H2O,,,UPLC-TQMS,2015,Arithmetic Mean,0.81,UPLC-TQMS: NASH Post-Prandial 60 mins,7.0
4,Altered Bile Acid Metabolome in Patients with Nonalcoholic Steatohepatitis,https://doi.org/10.1007/s10620-015-3776-8,Serum,15,Normal,Fed,LC-MS,nM,107.0,131.0,263.0,,15.4,233.0,50.4,441.0,115.0,77.2,68.4,150.0,97.3,3.7,3.8,408.4,331.4,801.3,,96.4,2.400852053,1.373884834,,,Healthy,Normal,Normal,7.0,8.0,,50ul serum. 150ul MeOH with IS. Vortex. Stand for 10min. Centrifuge. 160ul SN vacuum-dried. Reconstituted in equal volumes acetonitrile H2O. ,50.0,Methanol,Vacuum,Acetonitrile:H2O,,,UPLC-TQMS,2015,Arithmetic Mean,0.63,UPLC-TQMS: Healthy Post-Prandial 90 mins,15.0
5,Altered Bile Acid Metabolome in Patients with Nonalcoholic Steatohepatitis,https://doi.org/10.1007/s10620-015-3776-8,Serum,7,Unhealthy,Fasted,LC-MS,nM,236.0,355.0,431.0,,19.9,245.0,918.0,442.0,204.0,20.2,131.0,265.0,167.0,9.5,11.2,612.0,1538.0,1040.0,,51.3,2.315865246,0.606883721,NASH,,Liver,NASH,Metabolic,3.0,4.0,48.0,50ul serum. 150ul MeOH with IS. Vortex. Stand for 10min. Centrifuge. 160ul SN vacuum-dried. Reconstituted in equal volumes acetonitrile H2O. ,50.0,Methanol,Vacuum,Acetonitrile:H2O,,,UPLC-TQMS,2015,Arithmetic Mean,0.81,UPLC-TQMS: NASH Fasting,7.0
6,Altered Bile Acid Metabolome in Patients with Nonalcoholic Steatohepatitis,https://doi.org/10.1007/s10620-015-3776-8,Serum,7,Unhealthy,Fed,LC-MS,nM,160.0,433.0,571.0,,22.1,402.0,120.0,747.0,322.0,44.9,223.0,323.0,241.0,16.0,9.5,785.0,876.0,1559.0,,76.5,2.064244162,1.188139675,NASH,,Liver,NASH,Metabolic,3.0,4.0,48.0,50ul serum. 150ul MeOH with IS. Vortex. Stand for 10min. Centrifuge. 160ul SN vacuum-dried. Reconstituted in equal volumes acetonitrile H2O. ,50.0,Methanol,Vacuum,Acetonitrile:H2O,,,UPLC-TQMS,2015,Arithmetic Mean,0.81,UPLC-TQMS: NASH Post-Prandial 90 mins,7.0
7,Altered Bile Acid Metabolome in Patients with Nonalcoholic Steatohepatitis,https://doi.org/10.1007/s10620-015-3776-8,Serum,15,Normal,Fed,LC-MS,nM,115.0,135.0,273.0,,12.8,180.0,32.5,408.0,118.0,72.0,54.8,131.0,80.6,3.4,3.2,349.8,298.5,761.6,,88.0,2.02220978,1.497763381,,,Healthy,Normal,Normal,7.0,8.0,,50ul serum. 150ul MeOH with IS. Vortex. Stand for 10min. Centrifuge. 160ul SN vacuum-dried. Reconstituted in equal volumes acetonitrile H2O. ,50.0,Methanol,Vacuum,Acetonitrile:H2O,,,UPLC-TQMS,2015,Arithmetic Mean,0.63,UPLC-TQMS: Healthy Post-Prandial 120 mins,15.0
8,Altered Bile Acid Metabolome in Patients with Nonalcoholic Steatohepatitis,https://doi.org/10.1007/s10620-015-3776-8,Serum,7,Unhealthy,Fed,LC-MS,nM,120.0,414.0,518.0,,24.3,321.0,80.9,589.0,317.0,40.7,160.0,299.0,214.0,16.5,12.1,601.0,793.9,1321.0,,77.1,1.90485924,1.24137931,NASH,,Liver,NASH,Metabolic,3.0,4.0,48.0,50ul serum. 150ul MeOH with IS. Vortex. Stand for 10min. Centrifuge. 160ul SN vacuum-dried. Reconstituted in equal volumes acetonitrile H2O. ,50.0,Methanol,Vacuum,Acetonitrile:H2O,,,UPLC-TQMS,2015,Arithmetic Mean,0.81,UPLC-TQMS: NASH Post-Prandial 120 mins,7.0
9,Altered Bile Acid Metabolome in Patients with Nonalcoholic Steatohepatitis,https://doi.org/10.1007/s10620-015-3776-8,Serum,15,Normal,Fasted,LC-MS,nM,199.0,140.0,261.2,,13.4,73.3,388.0,128.0,55.6,14.1,21.5,49.2,27.1,1.9,1.3,293.8,577.2,416.3,,28.8,1.238591917,0.577037887,,,Healthy,Normal,Normal,7.0,8.0,,50ul serum. 150ul MeOH with IS. Vortex. Stand for 10min. Centrifuge. 160ul SN vacuum-dried. Reconstituted in equal volumes acetonitrile H2O. ,50.0,Methanol,Vacuum,Acetonitrile:H2O,,,UPLC-TQMS,2015,Arithmetic Mean,0.63,UPLC-TQMS: Healthy Fasting,15.0
10,Altered bile acid proﬁle associates with cognitive impairment in Alzheimer’s disease—An emerging role for gut microbiome,https://doi.org/10.1016/j.jalz.2018.07.217,Serum,305,Unknown,Fasted,LC-MS,uM,135.0,216.0,627.0,87.0,,297.0,806.0,672.0,136.0,39.0,66.0,97.0,77.0,8.0,6.0,498.0,1119.0,1376.0,231.0,,2.069483568,1.021645022,Alzheimer's Disease,,,,,166.0,139.0,74.7,Biocrates Bile Acid Kit,,,,,,,LC-MS/MS,2018,Arithmetic Mean,,LC-MS/MS: Mean; Alzheimer's Disease,305.0
11,Altered bile acid proﬁle associates with cognitive impairment in Alzheimer’s disease—An emerging role for gut microbiome,https://doi.org/10.1016/j.jalz.2018.07.217,Serum,284,Unknown,Fasted,LC-MS,uM,155.0,241.0,574.0,72.0,,234.0,724.0,488.0,114.0,34.0,57.0,88.0,59.0,8.0,5.0,446.0,1053.0,1121.0,194.0,,1.738003839,0.903268846,Early Mild Cognitive Impairment,,,,,154.0,130.0,71.12,Biocrates Bile Acid Kit,,,,,,,LC-MS/MS,2018,Arithmetic Mean,,LC-MS/MS: Mean; Early Mild Cognitive Impairment,284.0
12,Altered bile acid proﬁle associates with cognitive impairment in Alzheimer’s disease—An emerging role for gut microbiome,https://doi.org/10.1016/j.jalz.2018.07.217,Serum,505,Unknown,Fasted,LC-MS,uM,192.0,288.0,529.0,91.0,,239.0,710.0,502.0,129.0,30.0,68.0,91.0,65.0,8.0,5.0,499.0,1089.0,1096.0,228.0,,1.679090909,0.855793451,Late Mild Cognitive Impairment,,,,,308.0,197.0,73.95,Biocrates Bile Acid Kit,,,,,,,LC-MS/MS,2018,Arithmetic Mean,,LC-MS/MS: Mean; Late Mild Cognitive Impairment,505.0
13,Altered bile acid proﬁle associates with cognitive impairment in Alzheimer’s disease—An emerging role for gut microbiome,https://doi.org/10.1016/j.jalz.2018.07.217,Serum,370,Unknown,Fasted,LC-MS,uM,221.0,285.0,526.0,65.0,,236.0,658.0,440.0,115.0,27.0,68.0,90.0,58.0,8.0,5.0,525.0,1033.0,1024.0,188.0,,1.554238833,0.798459564,Cognitively Normal,,,,,180.0,190.0,84.58,Biocrates Bile Acid Kit,,,,,,,LC-MS/MS,2018,Arithmetic Mean,,LC-MS/MS: Mean; Cognitively Normal,370.0
14,Altered bile acid profile in mild cognitive impairment and Alzheimer's disease: Relationship to neuroimaging and CSF biomarkers,https://doi.org/10.1016/j.jalz.2018.08.012,Serum,98,Unknown,Fasted,LC-MS,uM,245.0,315.0,520.0,44.0,,269.0,702.0,462.0,93.0,25.0,90.0,114.0,77.0,8.0,4.0,604.0,1131.0,1059.0,145.0,,1.640569395,0.710662824,Subjective Memory Complaint,,,,,42.0,56.0,72.18,Biocrates Bile Acid Kit,,,,,,,LC-MS/MS,2018,Arithmetic Mean,,Subjective Memory Complaint,98.0
15,An integrated analysis of bile acid metabolism in humans with severe obesity,https://doi.org/10.1097/HEP.0000000000000938,Plasma,33,Both,Fasted,LC-MS,uM,36.0,67.0,153.0,21.0,4.0,70.0,183.0,117.0,33.0,6.0,16.0,27.0,17.0,1.0,1.0,122.0,277.0,287.0,55.0,11.0,1.676156584,0.884711779,Obesity,,,,,7.0,26.0,47.5,,50.0,Methanol,N2,Methanol:H2O,,,UPLC-MS/MS,2024,Median,,UPLC-MS/MS: Median; severe obesity undergoing bariatric surgery,33.0
16,Analysis of bile acid profile in plasma to differentiate cholangiocarcinoma from benign biliary diseases and healthy controls,https://doi.org/10.1016/j.jsbmb.2020.105775,Plasma,42,Unhealthy,Unknown,LC-MS,uM,119.0,120.0,282.0,113.0,8.0,44040.0,30140.0,689.0,2170.0,39.0,60610.0,22850.0,410.0,435.0,20.0,104769.0,53110.0,1381.0,2718.0,67.0,251.4065421,0.026387297,Cholangiocarcinoma,,Non-Liver,,,25.0,17.0,60.9,50ul plasma. 1oul IS and 140ul MeOH. Vortex. Centrifuge.,50.0,Methanol,No,,Direct Injection,,UPLC-MS/MS,2021,Arithmetic Mean,7.52,UPLC-MS/MS: Mean; Cholangiocarcinoma,42.0
17,Analysis of bile acid profile in plasma to differentiate cholangiocarcinoma from benign biliary diseases and healthy controls,https://doi.org/10.1016/j.jsbmb.2020.105775,Plasma,19,Unhealthy,Unknown,LC-MS,uM,334.0,652.0,215.0,108.0,18.0,1260.0,3974.0,506.0,546.0,26.0,467.0,831.0,129.0,51.0,14.0,2061.0,5457.0,850.0,705.0,58.0,5.880934439,0.214551742,HCC,,Liver,HCC,HCC,16.0,3.0,52.3,50ul plasma. 1oul IS and 140ul MeOH. Vortex. Centrifuge.,50.0,Methanol,No,,Direct Injection,,UPLC-MS/MS,2021,Arithmetic Mean,0.88,UPLC-MS/MS: Mean; HCC,19.0
18,Analysis of bile acid profile in plasma to differentiate cholangiocarcinoma from benign biliary diseases and healthy controls,https://doi.org/10.1016/j.jsbmb.2020.105775,Plasma,120,Unhealthy,Unknown,LC-MS,uM,398.0,931.0,418.0,230.0,21.0,694.0,2786.0,540.0,315.0,27.0,269.0,522.0,110.0,24.0,10.0,1361.0,4239.0,1068.0,569.0,58.0,2.651151151,0.302678571,Benign Biliary Disease,,Non-Liver,,,46.0,74.0,57.9,50ul plasma. 1ul IS and 140ul MeOH. Vortex. Centrifuge.,50.0,Methanol,No,,Direct Injection,,UPLC-MS/MS,2021,Arithmetic Mean,0.71,UPLC-MS/MS: Mean; Benign Biliary Disease,120.0
19,Analysis of bile acid profile in plasma to differentiate cholangiocarcinoma from benign biliary diseases and healthy controls,https://doi.org/10.1016/j.jsbmb.2020.105775,Plasma,28,Unhealthy,Unknown,LC-MS,uM,492.0,1064.0,398.0,252.0,15.0,551.0,2810.0,769.0,798.0,28.0,153.0,407.0,167.0,63.0,10.0,1196.0,4281.0,1334.0,1113.0,53.0,2.591625394,0.456454263,Gallbladder Cancer,,Non-Liver,,,13.0,15.0,62.4,50ul plasma. 1oul IS and 140ul MeOH. Vortex. Centrifuge.,50.0,Methanol,No,,Direct Injection,,UPLC-MS/MS,2021,Arithmetic Mean,1.3,UPLC-MS/MS: Mean; Gallbladder Cancer,28.0
20,Analysis of bile acid profile in plasma to differentiate cholangiocarcinoma from benign biliary diseases and healthy controls,https://doi.org/10.1016/j.jsbmb.2020.105775,Plasma,120,Normal,Unknown,LC-MS,uM,268.0,676.0,530.0,169.0,25.0,196.0,1678.0,469.0,188.0,23.0,33.0,182.0,82.0,17.0,9.0,497.0,2536.0,1081.0,374.0,57.0,1.724820144,0.49851632,,,Healthy,Normal,Normal,58.0,62.0,39.9,50ul plasma. 1ul IS and 140ul MeOH. Vortex. Centrifuge.,50.0,Methanol,No,,Direct Injection,,UPLC-MS/MS,2021,Arithmetic Mean,0.65,UPLC-MS/MS: Mean; Healthy,120.0
21,Analysis of the Serum Bile Acid Composition for Differential Diagnosis in Patients with Liver Disease,https://doi.org/10.1155/2015/717431,Serum,20,Unhealthy,Fasted,LC-MS,uM,69.5,104.7,32.2,88.4,17.7,1965.2,4901.2,178.2,793.9000000000001,15.0,690.0,1996.5,90.0,128.1,17.6,2724.7,7002.4,300.4,1010.4,50.3,34.48224,0.139928653,Biliary Tract Disease,,Non-Liver,,,14.0,6.0,66.5,20ul serum. 80ul ethanol and 20ul IS solution. Centrifuge. SN with water/formic acid (1000:1),20.0,Ethanol,No,,Direct Injection,,LC-MS/MS,2015,Least Squares Geometric Mean,2.09,LC-MS/MS: Geometric Mean; Biliary Tract Disease,20.0
22,Analysis of the Serum Bile Acid Composition for Differential Diagnosis in Patients with Liver Disease,https://doi.org/10.1155/2015/717431,Serum,29,Unhealthy,Fasted,LC-MS,uM,82.10000000000001,157.79999999999998,73.6,225.39999999999998,17.8,1438.3999999999999,3349.4,178.60000000000002,1087.6999999999998,22.9,491.5,1157.3,63.5,151.60000000000002,14.0,2012.0,4664.5,315.7,1464.6999999999998,54.699999999999996,14.28938387,0.274859582,Other Liver Diseases,,Liver,,,9.0,20.0,58.0,20ul serum. 80ul ethanol and 20ul IS solution. Centrifuge. SN with water/formic acid (1000:1),20.0,Ethanol,No,,Direct Injection,,LC-MS/MS,2015,Least Squares Geometric Mean,1.41,LC-MS/MS: Geometric Mean; Other Liver Diseases,29.0
23,Analysis of the Serum Bile Acid Composition for Differential Diagnosis in Patients with Liver Disease,https://doi.org/10.1155/2015/717431,Serum,67,Unhealthy,Fasted,LC-MS,uM,85.1,253.9,129.0,236.9,24.2,817.1,2835.6,232.0,899.8000000000001,23.3,228.9,830.8,76.7,107.6,14.5,1131.1,3920.3,437.7,1244.3,62.0,8.320257852,0.345250822,Viral Hepatitis,,Liver,,,40.0,27.0,59.9,20ul serum. 80ul ethanol and 20ul IS solution. Centrifuge. SN with water/formic acid (1000:1),20.0,Ethanol,No,,Direct Injection,,LC-MS/MS,2015,Least Squares Geometric Mean,1.18,LC-MS/MS: Geometric Mean; Viral Hepatitis,67.0
24,Analysis of the Serum Bile Acid Composition for Differential Diagnosis in Patients with Liver Disease,https://doi.org/10.1155/2015/717431,Serum,21,Unhealthy,Fasted,LC-MS,uM,130.3,552.5,78.8,1153.2,22.0,934.4,3762.9,144.9,3336.7,14.200000000000001,195.20000000000002,764.9,39.0,241.9,10.9,1259.9,5080.3,262.7,4731.8,47.1,4.876600578,0.795179963,ALD,,Liver,,,20.0,1.0,61.0,20ul serum. 80ul ethanol and 20ul IS solution. Centrifuge. SN with water/formic acid (1000:1),20.0,Ethanol,No,,Direct Injection,,LC-MS/MS,2015,Least Squares Geometric Mean,1.05,LC-MS/MS: Geometric Mean; ALD,21.0
25,Analysis of the Serum Bile Acid Composition for Differential Diagnosis in Patients with Liver Disease,https://doi.org/10.1155/2015/717431,Serum,13,Unhealthy,Fasted,LC-MS,uM,186.70000000000002,551.1,198.4,326.29999999999995,34.6,651.8000000000001,2632.7,253.0,727.6,27.599999999999998,114.7,399.5,62.7,55.300000000000004,9.5,953.2,3583.2999999999997,514.1,1109.2,71.7,3.804178552,0.373636063,NAFLD,,Liver,NAFLD,Metabolic,6.0,7.0,62.5,20ul serum. 80ul ethanol and 20ul IS solution. Centrifuge. SN with water/formic acid (1000:1),20.0,Ethanol,No,,Direct Injection,,LC-MS/MS,2015,Least Squares Geometric Mean,1.19,LC-MS/MS: Geometric Mean; NAFLD,13.0
26,Analysis of the Serum Bile Acid Composition for Differential Diagnosis in Patients with Liver Disease,https://doi.org/10.1155/2015/717431,Serum,46,Normal,Fasted,LC-MS,uM,63.8,344.5,266.5,197.5,10.3,123.5,546.0,157.0,211.0,7.1000000000000005,15.7,109.5,21.9,8.5,5.7,203.0,1000.0,445.40000000000003,417.0,23.099999999999998,1.366304102,0.736076475,,,Healthy,Normal,Normal,25.0,21.0,,20ul serum. 80ul ethanol and 20ul IS solution. Centrifuge. SN with water/formic acid (1000:1),20.0,Ethanol,No,,Direct Injection,,LC-MS/MS,2015,Median,0.8,LC-MS/MS: Median; Healthy controls,46.0
27,Assessment of serum bile acid profiles as biomarkers of liver injury and liver disease in humans,https://doi.org/10.1371/journal.pone.0193824,Serum,331,Unhealthy,Fed,LC-MS,ng/ml,466.71561429270673,708.6092715231787,224.6561385634233,,,13453.178694158076,17316.94839857651,2217.7491103202847,,,7748.109365910412,9175.305183109866,672.4034420652392,,,,,,,,43.01418058,0.061530802,Liver Injuries,,,,,186.0,145.0,46.4,50ul serum. 400ul 1% v/v fomic acid in acetonitrile for protein precipitation. 10ul IS added. Vortex. 10min centrifugation. SN evaporated under N2 at 40deg. Reconstituted in 100ul 50% v/v methanol in H2O,50.0,Acetonitrile,N2,Methanol:H2O,,,LC-MS/MS,2018,Arithmetic Mean,14.7,LC-MS/MS; Hepatic Injury,331.0
28,Assessment of serum bile acid profiles as biomarkers of liver injury and liver disease in humans,https://doi.org/10.1371/journal.pone.0193824,Serum,314,Normal,Both,LC-MS,ng/ml,150.7586882036221,293.93785022924095,523.6882322975038,,,468.85738831615123,1255.5604982206405,705.0711743772242,,,79.69749854566608,172.30338202921754,97.05823494096458,,,,,,,,3.333768949,0.525390984,,,Healthy,Normal,Normal,117.0,197.0,48.2,50ul serum. 400ul 1% v/v formic acid in acetonitrile for protein precipitation. 10ul IS added. Vortex. 10min centrifugation. SN evaporated under N2 at 40deg. Reconstituted in 100ul 50% v/v methanol in H2O,50.0,Acetonitrile,N2,Methanol:H2O,,,LC-MS/MS,2018,Arithmetic Mean,0.55,UPLC-TQMS: Median No-NAFLD,314.0
29,Association between circulating bile acid alterations and nonalcoholic steatohepatitis independent of obesity and diabetes mellitus,https://doi.org/10.1111/liv.15030,Serum,27,Unhealthy,Fed,LC-MS,nM,195.1,1455.0,629.6,235.4,,546.7,2960.7,283.2,,,109.7,449.2,31.4,12.2,,851.5,4864.9,944.2,,,1.746689992,0.208487859,NASH,,Liver,NASH,Metabolic,8.0,19.0,60.9,50ul serum extracted with 200ul MeOH dried using SpeedVac Concentrators ,50.0,Methanol,Vacuum,H2O;Ammonium Acetate;Methanol:Acetonitrile,,,UPLC-TQMS,2021,Median,,UPLC-TQMS: Median Nonobese NASH,27.0
30,Association between circulating bile acid alterations and nonalcoholic steatohepatitis independent of obesity and diabetes mellitus,https://doi.org/10.1111/liv.15030,Serum,45,Unhealthy,Fed,LC-MS,nM,87.2,658.4,706.3,98.1,,312.7,1218.6,296.4,,,110.8,420.6,84.6,12.0,,510.7,2297.6,1087.3,,,1.584322581,0.426378948,NASH,,Liver,NASH,Metabolic,20.0,25.0,48.4,50ul serum extracted with 200ul MeOH dried using SpeedVac Concentrators ,50.0,Methanol,Vacuum,H2O;Ammonium Acetate;Methanol:Acetonitrile,,,UPLC-TQMS,2021,Median,,UPLC-TQMS: Median Obese NASH,45.0
31,Association between circulating bile acid alterations and nonalcoholic steatohepatitis independent of obesity and diabetes mellitus,https://doi.org/10.1111/liv.15030,Serum,40,Normal,Fed,LC-MS,nM,71.8,349.3,600.0,70.7,,103.2,923.9,216.6,,,32.5,125.9,33.8,10.9,,207.5,1399.1,850.4,,,1.325151127,0.580107058,,,Healthy,Normal,Normal,15.0,25.0,52.8,50ul serum extracted with 200ul MeOH dried using SpeedVac Concentrators ,50.0,Methanol,Vacuum,H2O;Ammonium Acetate;Methanol:Acetonitrile,,,UPLC-TQMS,2021,Median,,UPLC-TQMS: Median; Nonobese;  No-NAFLD,40.0
32,Association between circulating bile acid alterations and nonalcoholic steatohepatitis independent of obesity and diabetes mellitus,https://doi.org/10.1111/liv.15030,Serum,20,Normal,Fed,LC-MS,nM,83.7,358.9,478.7,82.2,,88.2,726.5,107.5,,,45.0,108.8,28.0,9.9,,216.9,1194.2,614.2,,,1.110014948,0.5005315,,,Healthy,Normal,Normal,9.0,11.0,54.5,50ul serum extracted with 200ul MeOH dried using SpeedVac Concentrators ,50.0,Methanol,Vacuum,H2O;Ammonium Acetate;Methanol:Acetonitrile,,,UPLC-TQMS,2021,Median,,UPLC-TQMS: Median Obese No-NAFLD,20.0
33,Association between circulating bile acid alterations and nonalcoholic steatohepatitis independent of obesity and diabetes mellitus,https://doi.org/10.1111/liv.15030,Serum,42,Unhealthy,Fed,LC-MS,nM,91.4,551.4,711.9,69.6,,92.4,712.9,109.8,,,27.2,83.5,47.3,13.9,,211.0,1347.8,869.0,,,0.763181914,0.611046959,NAFL,,Liver,NAFL,Metabolic,22.0,20.0,59.9,50ul serum extracted with 200ul MeOH dried using SpeedVac Concentrators ,50.0,Methanol,Vacuum,H2O;Ammonium Acetate;Methanol:Acetonitrile,,,UPLC-TQMS,2021,Median,,UPLC-TQMS: Median Nonobese NAFL,42.0
34,Association between circulating bile acid alterations and nonalcoholic steatohepatitis independent of obesity and diabetes mellitus,https://doi.org/10.1111/liv.15030,Serum,51,Unhealthy,Fed,LC-MS,nM,151.4,802.3,629.3,89.1,,172.3,613.4,164.1,,,45.6,96.2,33.8,10.0,,369.3,1511.9,827.2,,,0.679026374,0.492398469,NAFL,,Liver,NAFL,Metabolic,31.0,20.0,50.0,50ul serum extracted with 200ul MeOH dried using SpeedVac Concentrators ,50.0,Methanol,Vacuum,H2O;Ammonium Acetate;Methanol:Acetonitrile,,,UPLC-TQMS,2021,Median,,UPLC-TQMS: Median Obese NAFL,51.0
35,Association between Pre-Diagnostic Serum Bile Acids and Hepatocellular Carcinoma: The Singapore Chinese Health Study,https://doi.org/10.3390/cancers13112648,Serum,100,Unhealthy,Unknown,LC-MS,nM,100.0,920.0,629.0,243.0,,796.0,6234.0,839.0,15.0,,169.0,675.0,124.0,23.2,,1065.0,7829.0,1592.0,281.2,,4.690909091,0.210613897,HCC,,Liver,HCC,HCC,75.0,25.0,66.3,50ul serum. 150ul MeOH with IS. Vortex. Stand for 10min. Centrifuge. 160ul SN vacuum-dried. Reconstituted in equal volumes acetonitrile H2O. ,50.0,Methanol,Vacuum,Acetonitrile:H2O,,,UPLC-TQMS,2021,Geometric Mean,,UPLC-TQMS:Geometric Mean; HCC,100.0
36,Association between Pre-Diagnostic Serum Bile Acids and Hepatocellular Carcinoma: The Singapore Chinese Health Study,https://doi.org/10.3390/cancers13112648,Serum,100,Normal,Unknown,LC-MS,nM,95.0,825.0,773.0,145.0,,211.0,1883.0,566.0,11.8,,36.0,110.0,45.0,14.2,,342.0,2818.0,1384.0,171.0,,1.565288357,0.492088608,,,Healthy,Normal,Normal,75.0,25.0,66.4,50ul serum. 150ul MeOH with IS. Vortex. Stand for 10min. Centrifuge. 160ul SN vacuum-dried. Reconstituted in equal volumes acetonitrile H2O. ,50.0,Methanol,Vacuum,Acetonitrile:H2O,,,UPLC-TQMS,2021,Geometric Mean,,UPLC-TQMS: Geometric Mean,100.0
37,Association of Serum and Fecal Bile Acid Patterns With Liver Fibrosis in Biopsy-Proven Disease: An Observational Study Nonalcoholic Fatty Liver,https://doi.org/10.14309/ctg.0000000000000503,Serum,55,Normal,Fasted,LC-MS,uM,270.0,1240.0,450.0,750.0,460.0,,,,,,,,,,,440.0,2590.0,1430.0,1400.0,660.0,1.057,1.151815182,,,,Normal,Normal,,,,20ul serum. IS and 20ul ethanol:H2O 9:1. Diluted with 2ml 0.5 M potassium phosphate buffer. Passed through Bond Elut C18 cartridges. Cartridge washed with 1.6ml water. BAs eluted in 3ml ethanol:water 9:1. Evaporated at 100deg under N2. Redissolved in 20mM ammonium acetate buffer (pH 7.5):MeOH 1:1. Centrifuge. SN injected.,20.0,Ethanol:H2O,N2,Ammonium Acetate:Methanol,SPE,,LC-ESI-MS/MS,2022,Arithmetic Mean,,LC-ESI-MS/MS: Mean; Healthy,
38,Association of Serum and Fecal Bile Acid Patterns With Liver Fibrosis in Biopsy-Proven Disease: An Observational Study Nonalcoholic Fatty Liver,https://doi.org/10.14309/ctg.0000000000000503,Serum,52,Unhealthy,Fasted,LC-MS,uM,800.0,2090.0,410.0,1090.0,730.0,,,,,,,,,,,1180.0,2640.0,960.0,1750.0,1030.0,0.475,0.771626298,NAFLD Mild Fibrosis,,Liver,NAFLD,Metabolic,,,,20ul serum. IS and 20ul ethanol:H2O 9:1. Diluted with 2ml 0.5 M potassium phosphate buffer. Passed through Bond Elut C18 cartridges. Cartridge washed with 1.6ml water. BAs eluted in 3ml ethanol:water 9:1. Evaporated at 100deg under N2. Redissolved in 20mM ammonium acetate buffer (pH 7.5):MeOH 1:1. Centrifuge. SN injected.,20.0,Ethanol:H2O,N2,Ammonium Acetate:Methanol,SPE,,LC-ESI-MS/MS,2022,Arithmetic Mean,,LC-ESI-MS/MS: Mean; NAFLD (Mild Fibrosis),
39,Association of Serum and Fecal Bile Acid Patterns With Liver Fibrosis in Biopsy-Proven Disease: An Observational Study Nonalcoholic Fatty Liver,https://doi.org/10.14309/ctg.0000000000000503,Serum,34,Unhealthy,Fasted,LC-MS,uM,1390.0,2450.0,1350.0,830.0,1110.0,,,,,,,,,,,1940.0,3260.0,1940.0,1500.0,1450.0,0.415,0.856770833,NAFLD Advanced Fibrosis,,Liver,NAFLD,Metabolic,,,,20ul serum. IS and 20ul ethanol:H2O 9:1. Diluted with 2ml 0.5 M potassium phosphate buffer. Passed through Bond Elut C18 cartridges. Cartridge washed with 1.6ml water. BAs eluted in 3ml ethanol:water 9:1. Evaporated at 100deg under N2. Redissolved in 20mM ammonium acetate buffer (pH 7.5):MeOH 1:1. Centrifuge. SN injected.,20.0,Ethanol:H2O,N2,Ammonium Acetate:Methanol,SPE,,LC-ESI-MS/MS,2022,Arithmetic Mean,,LC-ESI-MS/MS: Mean; NAFLD (Advanced Fibrosis),
40,Bile Acid Alterations Are Associated With Insulin Resistance; but Not With NASH; in Obese Subjects,https://doi.org/10.1210/jc.2017-01397,Plasma,26,Normal,Fasted,LC-MS,nM,37.0,97.0,177.0,,0.0,82.0,235.0,58.0,,8.0,15.0,32.0,10.0,,1.0,134.0,364.0,245.0,,9.0,1.418006431,0.510040161,,,Healthy,Normal,Normal,3.0,23.0,40.5,50ul serum. 325ul 1/100 dilution IS solution. 225ul cold MeOH added for protein precipitation. Vortex. Kept at -20deg for 20mins; Centrifuge. SN dried in Savant speedvac concentrator. Reconsititute in 50ul MeOH:H20 50:50 v/v. Centrifuge,50.0,Methanol,Vacuum,Methanol:H2O,,,LC-MS/MS,2017,Median,0.49,LC-MS/MS: Median; No-NASH; normal liver; or minor lesions; as well as no fibrosis,26.0
41,Bile Acid Alterations Are Associated With Insulin Resistance; but Not With NASH; in Obese Subjects,https://doi.org/10.1210/jc.2017-01397,Plasma,32,Unhealthy,Fasted,LC-MS,nM,27.0,77.0,250.0,,0.0,88.0,210.0,85.0,,7.0,15.0,31.0,14.0,,1.0,130.0,318.0,349.0,,8.0,1.274011299,0.796875,NASH,,Liver,NASH,Metabolic,13.0,19.0,41.3,50ul serum. 325ul 1/100 dilution IS solution. 225ul cold MeOH added for protein precipitation. Vortex. Kept at -20deg for 20mins; Centrifuge. SN dried in Savant speedvac concentrator. Reconsititute in 50ul MeOH:H20 50:50 v/v. Centrifuge,50.0,Methanol,Vacuum,Methanol:H2O,,,LC-MS/MS,2017,Median,0.56,LC-MS/MS: Median; NASH,32.0
42,Bile Acid Profiles Are Distinct among Patients with Different Etiologies of Chronic Liver Disease,https://doi.org/10.1021/acs.jproteome.0c00852,Serum,37,Unhealthy,Fasted,LC-MS,nM,1294.89,913.44,107.86,699.21,35.64,5376.38,14338.61,380.25,3394.88,42.142,2223.07,6774.66,244.4,881.0,13.63,8894.34,22026.71,732.51,4975.09,91.412,11.03526076,0.187542532,ALD,,Liver,,,37.0,0.0,56.78,50ul serum. 150ul MeOH with IS. Vortex. Stand for 10min. Centrifuge. 160ul SN vacuum-dried. Reconstituted in equal volumes acetonitrile H2O. ,50.0,Methanol,Vacuum,Acetonitrile:H2O,,,UPLC-TQMS,2021,Arithmetic Mean,4.72,UPLC-TQMS: Mean; ALD,37.0
43,Bile Acid Profiles Are Distinct among Patients with Different Etiologies of Chronic Liver Disease,https://doi.org/10.1021/acs.jproteome.0c00852,Serum,57,Unhealthy,Fasted,LC-MS,nM,514.23,478.31,102.91,1725.86,18.12,4784.93,6519.32,199.67,9072.45,26.8,1652.45,2613.9,113.27,1395.93,3.79,6951.61,9611.53,415.85,12194.24,48.71,9.291481037,0.764275373,Primary Biliary Cirrhosis,,Liver,Cirrhosis,Metabolic,7.0,50.0,61.3,50ul serum. 150ul MeOH with IS. Vortex. Stand for 10min. Centrifuge. 160ul SN vacuum-dried. Reconstituted in equal volumes acetonitrile H2O. ,50.0,Methanol,Vacuum,Acetonitrile:H2O,,,UPLC-TQMS,2021,Arithmetic Mean,2.33,UPLC-TQMS: Mean; Primary Biliary Cirrhosis,57.0
44,Bile Acid Profiles Are Distinct among Patients with Different Etiologies of Chronic Liver Disease,https://doi.org/10.1021/acs.jproteome.0c00852,Serum,400,Unhealthy,Fasted,LC-MS,nM,146.39,197.89,80.02,39.61,1.36,924.69,1759.09,251.18,69.6,3.07,275.51,455.42,73.62,8.83,1.99,1346.59,2412.4,404.82,118.04,6.42,8.216734369,0.14080378,Hep B,,Liver,,,304.0,96.0,34.07,50ul serum. 150ul MeOH with IS. Vortex. Stand for 10min. Centrifuge. 160ul SN vacuum-dried. Reconstituted in equal volumes acetonitrile H2O. ,50.0,Methanol,Vacuum,Acetonitrile:H2O,,,UPLC-TQMS,2021,Arithmetic Mean,1.26,UPLC-TQMS: Mean; Hep B,400.0
45,Bile Acid Profiles Are Distinct among Patients with Different Etiologies of Chronic Liver Disease,https://doi.org/10.1021/acs.jproteome.0c00852,Serum,11,Unhealthy,Fasted,LC-MS,nM,186.12,339.67,57.45,83.62,0.99,387.77,1526.32,118.72,67.96,1.64,72.88,180.02,21.1,15.59,1.62,646.77,2046.01,197.27,167.17,4.25,3.584068279,0.136917981,Hep C,,Liver,,,8.0,3.0,40.4,50ul serum. 150ul MeOH with IS. Vortex. Stand for 10min. Centrifuge. 160ul SN vacuum-dried. Reconstituted in equal volumes acetonitrile H2O. ,50.0,Methanol,Vacuum,Acetonitrile:H2O,,,UPLC-TQMS,2021,Arithmetic Mean,1.02,UPLC-TQMS: Mean; Hep C,11.0
46,Bile Acid Profiles Are Distinct among Patients with Different Etiologies of Chronic Liver Disease,https://doi.org/10.1021/acs.jproteome.0c00852,Serum,153,Normal,Fasted,LC-MS,nM,57.43,134.55,60.19,41.89,1.37,67.84,252.14,44.36,23.48,1.37,9.01,17.93,568.0,1.56,1.12,134.28,404.62,672.55,66.93,3.86,3.340249805,1.379365374,,,Healthy,Normal,Normal,108.0,45.0,38.92,50ul serum. 150ul MeOH with IS. Vortex. Stand for 10min. Centrifuge. 160ul SN vacuum-dried. Reconstituted in equal volumes acetonitrile H2O. ,50.0,Methanol,Vacuum,Acetonitrile:H2O,,,UPLC-TQMS,2021,Arithmetic Mean,0.89,UPLC-TQMS: Mean; Healthy Control,153.0
47,Bile Acid Profiles Are Distinct among Patients with Different Etiologies of Chronic Liver Disease,https://doi.org/10.1021/acs.jproteome.0c00852,Serum,214,Unhealthy,Fasted,LC-MS,nM,196.59,488.49,196.34,263.18,4.3,2079.35,992.22,185.3,148.34,5.9,63.32,110.15,27.35,7.46,1.44,2339.26,1590.86,408.99,418.98,11.64,3.151562364,0.213634698,NASH,,Liver,NASH,Metabolic,109.0,105.0,44.8,50ul serum. 150ul MeOH with IS. Vortex. Stand for 10min. Centrifuge. 160ul SN vacuum-dried. Reconstituted in equal volumes acetonitrile H2O. ,50.0,Methanol,Vacuum,Acetonitrile:H2O,,,UPLC-TQMS,2021,Arithmetic Mean,,UPLC-TQMS: Mean; NASH,214.0
48,Bile acid profiling in human biological samples: Comparison of extraction procedures and application to normal and cholestatic patients.,https://doi.org/10.1016/j.jchromb.2012.05.015,Serum,9,Unhealthy,Fasted,LC-MS,nM,40.0,,15.0,,,25030.0,12370.0,680.0,40.0,,53920.0,18130.0,1030.0,30.0,,78990.0,,1725.0,,,2022.363636,0.016394191,Cholestasis,,,,,,,,500 ul serum Acetonitrile deproteinization; followed by evaporation and solid phase extraction,500.0,Acetonitrile,N2,Ammonium Acetate,SPE,,LC-MS/MS,2012,Arithmetic Mean,,LC-MS/MS: Mean; Cholestatic,
49,Bile acid profiling in human biological samples: Comparison of extraction procedures and application to normal and cholestatic patients.,https://doi.org/10.1016/j.jchromb.2012.05.015,Serum,23,Normal,Fasted,LC-MS,nM,65.0,130.0,240.0,20.0,30.0,190.0,720.0,390.0,14.0,,62.0,95.0,80.0,,,317.0,,710.0,,,3.197938144,0.613312203,,,Healthy,Normal,Normal,,,,500 ul serum Acetonitrile deproteinization; followed by evaporation and solid phase extraction,500.0,Acetonitrile,N2,Ammonium Acetate,SPE,,LC-MS/MS,2012,Arithmetic Mean,,LC-MS/MS: Mean; Healthy Control,
50,Bile acid profiling in human biological samples: Comparison of extraction procedures and application to normal and cholestatic patients.,https://doi.org/10.1016/j.jchromb.2012.05.015,Serum,39,Normal,Fasted,LC-MS,nM,169.12,177.84,242.9,57.91,,112.81,705.03,255.25,99.62,,41.15,83.43,47.89,,,323.08,966.3,546.04,157.53,,2.076632138,0.545665359,,,Healthy,Normal,Normal,,,,500 ul serum Acetonitrile deproteinization; followed by evaporation and solid phase extraction,500.0,Acetonitrile,N2,Ammonium Acetate,SPE,,LC-MS/MS,2012,Arithmetic Mean,,LC-MS/MS: Mean; Healthy Control,
51,Bile acid quantification of 20 plasma metabolites identifies lithocholic acid as a putative biomarker in Alzheimer’s disease.,https://doi.org/10.1007/s11306-017-1297-5,Plasma,20,Unknown,Unknown,LC-MS,nM,155.0,284.0,207.0,62.0,41.0,207.0,1156.0,504.0,137.0,27.0,40.0,170.0,72.0,8.0,5.0,402.0,1610.0,783.0,207.0,73.0,3.105473965,0.52833002,Mild Cognitive Impairment,,,,,9.0,21.0,78.0,Biocrates Bile Acid Kit,,,,,,,UHPLC-MS,2017,Arithmetic Mean,,UHPLC-MS: Mean; Mild Cognitive Impairment; no liver info,30.0
52,Bile acid quantification of 20 plasma metabolites identifies lithocholic acid as a putative biomarker in Alzheimer’s disease.,https://doi.org/10.1007/s11306-017-1297-5,Plasma,30,Unknown,Unknown,LC-MS,nM,215.0,361.0,423.0,88.0,32.0,423.0,1326.0,640.0,160.0,41.0,134.0,211.0,97.0,8.0,8.0,772.0,1898.0,1160.0,256.0,81.0,2.72386059,0.560674157,,,,,,8.0,22.0,77.0,Biocrates Bile Acid Kit,,,,,,,UHPLC-MS,2017,Arithmetic Mean,,UHPLC-MS: Mean; Control; no liver info,30.0
53,Bile acid quantification of 20 plasma metabolites identifies lithocholic acid as a putative biomarker in Alzheimer’s disease.,https://doi.org/10.1007/s11306-017-1297-5,Plasma,20,Unknown,Unknown,LC-MS,nM,224.0,1245.0,332.0,209.0,50.0,332.0,1951.0,956.0,137.0,66.0,99.0,347.0,152.0,11.0,11.0,655.0,3543.0,1440.0,357.0,127.0,1.97184466,0.458313483,Alzheimer's Disease,,,,,9.0,11.0,79.0,Biocrates Bile Acid Kit,,,,,,,UHPLC-MS,2017,Arithmetic Mean,,UHPLC-MS: Mean; Alzheimer's Disease; no liver info,20.0
54,Bile acids associate with glucose metabolism; but do not predict conversion from impaired fasting glucose to diabetes,https://doi.org/10.1016/j.metabol.2019.154042,Plasma,205,Both,Fasted,LC-MS,nM,,,,,,,,,,,,,,,,257.7,648.9,417.0,81.4,16.4,,,,,,,,141.0,64.0,56.0,50ul plasma. 325ul 1/100 dilution IS solution. 225ul cold MeOH added for protein precipitation. Vortex. Kept at -20deg for 20mins; Centrifuge. SN dried in Savant speedvac concentrator. Reconsititute in 50ul MeOH:H20 50:50 v/v. Centrifuge,50.0,Methanol,Vacuum,Methanol:H2O,,,LC-MS/MS,2019,Arithmetic Mean,,LC-MS/MS: Mean,205.0
55,Bile acids profile; histopathological indices and genetic variants for non-alcoholic fatty liver disease progression,https://doi.org/10.1016/j.metabol.2020.154457,Plasma,102,Unhealthy,Fasted,LC-MS,nM,72.8,227.8,374.9,27.4,18.2,522.0,1442.1,409.7,197.1,13.4,70.2,211.5,63.4,5.7,4.6,665.0,1881.4,848.0,230.2,36.2,4.076688393,0.437637449,NAFLD,,Liver,NAFLD,Metabolic,53.0,49.0,52.3,20ul plasma. Mix with 80ul ice cold MeOH IS mixture. Vortex. Centrifuge. SN analysed,20.0,Methanol,,,Direct Injection,,HPLC-MS/MS,2020,Median,,HPLC-MS/MS: Median NAFLD,102.0
56,Bile acids profile; histopathological indices and genetic variants for non-alcoholic fatty liver disease progression,https://doi.org/10.1016/j.metabol.2020.154457,Plasma,50,Normal,Fasted,LC-MS,nM,44.8,68.0,251.9,34.4,27.7,105.1,383.4,136.7,61.0,9.5,12.8,44.8,19.9,2.0,4.4,162.7,496.2,408.5,97.4,41.6,1.826616682,0.830930338,,,Healthy,Normal,Normal,,,,20ul plasma. Mix with 80ul ice cold MeOH IS mixture. Vortex. Centrifuge. SN analysed,20.0,Methanol,,,Direct Injection,,HPLC-MS/MS,2020,Median,,HPLC-MS/MS: Median,
57,Circulating bile acid concentrations and non-alcoholic fatty liver disease in Guatemala,https://doi.org/10.1111/apt.16948,Serum,251,Unhealthy,Fasted,LC-MS,ng/ml,74.40039158100831,226.6938359653591,259.80641874681606,26.235354049923586,11.763143919277747,160.22336769759448,531.5836298932385,135.00889679715303,38.92348754448399,6.642066420664206,10.994764397905758,44.82689613768261,10.646387832699622,,,110.67,350.4,168.02,,,1.812857324,0.440562171,NAFLD,,Liver,NAFLD,Metabolic,84.0,167.0,54.3,,,,,,,,LC-MS/MS,2022,Arithmetic Mean,,LC-MS/MS: Mean; NAFLD,251.0
58,Circulating bile acid concentrations and non-alcoholic fatty liver disease in Guatemala,https://doi.org/10.1111/apt.16948,Serum,164,Normal,Fasted,LC-MS,ng/ml,75.99118942731278,194.34538970962808,211.41110545084052,21.421293937850226,9.506107275624004,99.11941580756013,451.51245551601426,107.4288256227758,36.588078291814945,7.67988929889299,2.423889858444832,25.91554932959776,5.003001801080648,,,78.45,292.25,133.8,,,1.65034101,0.446641489,No-NAFLD,,Healthy,Normal,Normal,82.0,82.0,56.9,,,,,,,,LC-MS/MS,2022,Arithmetic Mean,,LC-MS/MS: Mean; Healthy Control,164.0
59,Concentration of unsulfated lithocholic acid in portal and systemic venous plasma: evidence that lithocholic acid does not down regulate the hepatic cholesterol 7?-hydroxylase activity in gallstone patients.,https://doi.org/10.1016/0925-4439(96)00030-0,Serum,7,Unhealthy,Fasted,GC-MS,uM,,,,,,,,,,,,,,,,300.0,410.0,410.0,,30.0,,,Cholelithiasis,,Non-Liver,,,1.0,6.0,58.0,500ul plasma; 100ng IS dissolved in 20ul ethanol added. Dilute in 2ml aqueous ethanol. Alkaline hydrolysis 120deg 16h. Dilutewith saline and extract twice with diethylether to remove neutral steroids. Acidification with HCl; BAs extracted with diethylether. Methylated with diazomethane. Trichlorosilane and hexamethylsilazane. Evaporate to dryness and dissolve in hexane ,500.0,,,,,,GC-MS,1996,Arithmetic Mean,,GC-MS: Mean; Gallstone/Cholithiasis,7.0
60,Determination of sulfated and nonsulfated bile acids in serum by mass fragmentography,https://doi.org/10.1016/0039-128X(83)90121-6,Serum,15,Normal,Fasted,GC-MS,ug/ml,797.8463044542339,1357.6158940397352,970.4533876719306,114.62047885888944,37.174721189591075,,,,,,,,,,,,,,,,,0.512223516,,,Healthy,Normal,Normal,7.0,8.0,,0.5ml serum diluted in 0.5M phosphate buffer;introduced to Sep-Pak C18 cartridge; sulfated and non-sulfated bile acids separated on PHP-LH-20 column. Alkaline hydrolysis 4h with 2ml 4M aqueous NaOH at 120deg in autoclave. Hydrolysate acidified to pH1 with 2M HCl and extracted with ether 3 times. Ether extracts evaporated to driness and derivatized to HFIP-TFA conjugates ,500.0,,,,,,GC-MS,1983,Arithmetic Mean,,GC-MS: Arithmetic Mean; Normal Levels of Serum  Bilirubin,15.0
61,Determination of sulfated and nonsulfated bile acids in serum by mass fragmentography,https://doi.org/10.1016/0039-128X(83)90121-6,Serum,8,Unhealthy,Fasted,GC-MS,ug/ml,58690.651003426334,40458.48191543556,1321.9561895058582,0.0,130.11152416356876,,,,,,,,,,,,,,,,,0.014248087,Obstructive jaundice,,Liver,,,4.0,4.0,,0.5ml serum diluted in 0.5M phosphate buffer;introduced to Sep-Pak C18 cartridge; sulfated and non-sulfated bile acids separated on PHP-LH-20 column. Alkaline hydrolysis 4h with 2ml 4M aqueous NaOH at 120deg in autoclave. Hydrolysate acidified to pH1 with 2M HCl and extracted with ether 3 times. Ether extracts evaporated to driness and derivatized to HFIP-TFA conjugates ,500.0,,,,,,GC-MS,1983,Arithmetic Mean,,GC-MS: Arithmetic Mean; Obstructive Jaundice,8.0
62,Determination of sulfated and nonsulfated bile acids in serum by mass fragmentography,https://doi.org/10.1016/0039-128X(83)90121-6,Serum,8,Unhealthy,Fasted,GC-MS,ug/ml,6064.610866372981,9875.19103413143,896.5868568517574,295.4661232806928,61.07275624004248,,,,,,,,,,,,,,,,,0.077261998,Cirrhosis,,Liver,Cirrhosis,Metabolic,7.0,1.0,,0.5ml serum diluted in 0.5M phosphate buffer;introduced to Sep-Pak C18 cartridge; sulfated and non-sulfated bile acids separated on PHP-LH-20 column. Alkaline hydrolysis 4h with 2ml 4M aqueous NaOH at 120deg in autoclave. Hydrolysate acidified to pH1 with 2M HCl and extracted with ether 3 times. Ether extracts evaporated to driness and derivatized to HFIP-TFA conjugates ,500.0,,,,,,GC-MS,1983,Arithmetic Mean,,GC-MS: Arithmetic Mean; Cirrhosis,8.0
63,Diagnostic sensitivity of fasting and postprandial serum bile acids determined by different methods.,https://doi.org/10.1016/0009-8981(87)90446-3,Serum,20,Normal,Fasted,GLC,uM,,,,,,,,,,,,,,,,300.0,790.0,570.0,160.0,250.0,,,,,Healthy,Normal,Normal,,,,0.5-2ml serum using Amberlite XAD-2; solvolysis of sulfate groups; enzymatic hydrolysis of G- and T- conjugates; extraction of uBAs with diethylether at pH 1.0 with conc. HCl. Free acids methylated using acidified mixture of methanol and 2.2-dimethyoxypropane (1:1 v/v) and trimethyl silyayed using a mixture of hexamethyldisasane and trimethylcholorosilane in pyridine (2:1:3 v/v) at RT for 30 mins,,,,,,,Capilliary gas-liquid chromatography,1987,Arithmetic Mean,,Capilliary gas-liquid chromatography: Mean; Healthy controls,
64,Diagnostic sensitivity of fasting and postprandial serum bile acids determined by different methods.,https://doi.org/10.1016/0009-8981(87)90446-3,Serum,20,Normal,Fed,GLC,uM,,,,,,,,,,,,,,,,720.0,2140.0,1400.0,560.0,480.0,,,,,Healthy,Normal,Normal,,,,0.5-2ml serum using Amberlite XAD-2; solvolysis of sulfate groups; enzymatic hydrolysis of G- and T- conjugates; extraction of uBAs with diethylether at pH 1.0 with conc. HCl. Free acids methylated using acidified mixture of methanol and 2.2-dimethyoxypropane (1:1 v/v) and trimethyl silyayed using a mixture of hexamethyldisasane and trimethylcholorosilane in pyridine (2:1:3 v/v) at RT for 30 mins,,,,,,,Capilliary gas-liquid chromatography,1987,Arithmetic Mean,,Capilliary gas-liquid chromatography: Mean; Healthy controls; 2 hours after standardised meal,
65,Diagnostic sensitivity of fasting and postprandial serum bile acids determined by different methods.,https://doi.org/10.1016/0009-8981(87)90446-3,Serum,43,Unhealthy,Fasted,GLC,uM,,,,,,,,,,,,,,,,16500.0,18700.0,3100.0,1800.0,1300.0,,,Cirrhosis,,Liver,Cirrhosis,Metabolic,30.0,13.0,48.6,0.5-2ml serum using Amberlite XAD-2; solvolysis of sulfate groups; enzymatic hydrolysis of G- and T- conjugates; extraction of uBAs with diethylether at pH 1.0 with conc. HCl. Free acids methylated using acidified mixture of methanol and 2.2-dimethyoxypropane (1:1 v/v) and trimethyl silyayed using a mixture of hexamethyldisasane and trimethylcholorosilane in pyridine (2:1:3 v/v) at RT for 30 mins,,,,,,,Capilliary gas-liquid chromatography,1987,Arithmetic Mean,,Capilliary gas-liquid chromatography: Mean; Cirrhotic (biopsy-proven of laparoscopy),43.0
66,Diagnostic sensitivity of fasting and postprandial serum bile acids determined by different methods.,https://doi.org/10.1016/0009-8981(87)90446-3,Serum,43,Unhealthy,Fed,GLC,uM,,,,,,,,,,,,,,,,29300.0,39600.0,5400.0,2800.0,2700.0,,,Cirrhosis,,Liver,Cirrhosis,Metabolic,30.0,13.0,48.6,0.5-2ml serum using Amberlite XAD-2; solvolysis of sulfate groups; enzymatic hydrolysis of G- and T- conjugates; extraction of uBAs with diethylether at pH 1.0 with conc. HCl. Free acids methylated using acidified mixture of methanol and 2.2-dimethyoxypropane (1:1 v/v) and trimethyl silyayed using a mixture of hexamethyldisasane and trimethylcholorosilane in pyridine (2:1:3 v/v) at RT for 30 mins,,,,,,,Capilliary gas-liquid chromatography,1987,Arithmetic Mean,,Capilliary gas-liquid chromatography: Mean;  Cirrhotic (biopsy-proven of laparoscopy); 2 hours after standardised meal,43.0
67,Distinct Postprandial Bile Acids Responses to a High-Calorie Diet in Men Volunteers Underscore Metabolically Healthy and Unhealthy Phenotypes,https://doi.org/10.3390/nu12113545,Plasma,71,Normal,Fed,LC-MS,uM,60.0,130.0,250.0,35.0,130.0,220.0,1840.0,490.0,,,85.0,370.0,180.0,,,365.0,2340.0,920.0,,,5.26446281,0.401109057,,,Healthy,Normal,Normal,71.0,0.0,30.1,100ul plasma deproteinized with acetonitrile (final conc 80& v/v) containing 25ug Nor and 10ug C4-D7. Vortex. Incubate 20min at RT and centrifuge. Evaporate SN under N2 at 50deg resuspend in150ul methanol.,100.0,Acetonitrile,N2,Methanol,,,HPLC-MS/MS,2020,Arithmetic Mean,,HPLC-MS/MS,71.0
68,Distinct Postprandial Bile Acids Responses to a High-Calorie Diet in Men Volunteers Underscore Metabolically Healthy and Unhealthy Phenotypes,https://doi.org/10.3390/nu12113545,Plasma,71,Normal,Fed,LC-MS,uM,70.0,200.0,390.0,52.0,240.0,230.0,1750.0,540.0,,,100.0,390.0,230.0,,,400.0,2340.0,1160.0,,,3.403361345,0.529927007,,,Healthy,Normal,Normal,71.0,0.0,30.1,100ul plasma deproteinized with acetonitrile (final conc 80& v/v) containing 25ug Nor and 10ug C4-D7. Vortex. Incubate 20min at RT and centrifuge. Evaporate SN under N2 at 50deg resuspend in150ul methanol.,100.0,Acetonitrile,N2,Methanol,,,HPLC-MS/MS,2020,Arithmetic Mean,,HPLC-MS/MS,71.0
69,Distinct Postprandial Bile Acids Responses to a High-Calorie Diet in Men Volunteers Underscore Metabolically Healthy and Unhealthy Phenotypes,https://doi.org/10.3390/nu12113545,Plasma,71,Normal,Fasted,LC-MS,uM,120.0,200.0,290.0,48.0,56.0,110.0,760.0,230.0,,,47.0,140.0,150.0,,,277.0,1100.0,670.0,,,2.012605042,0.562091503,,,Healthy,Normal,Normal,71.0,0.0,30.1,100ul plasma deproteinized with acetonitrile (final conc 80& v/v) containing 25ug Nor and 10ug C4-D7. Vortex. Incubate 20min at RT and centrifuge. Evaporate SN under N2 at 50deg resuspend in150ul methanol.,100.0,Acetonitrile,N2,Methanol,,,HPLC-MS/MS,2020,Arithmetic Mean,,HPLC-MS/MS: Fasted,71.0
70,Distinct Postprandial Bile Acids Responses to a High-Calorie Diet in Men Volunteers Underscore Metabolically Healthy and Unhealthy Phenotypes,https://doi.org/10.3390/nu12113545,Plasma,71,Normal,Fed,LC-MS,uM,140.0,230.0,280.0,42.0,600.0,170.0,1400.0,350.0,,,62.0,260.0,160.0,,,372.0,1890.0,790.0,,,1.859133127,0.633068081,,,Healthy,Normal,Normal,71.0,0.0,30.1,100ul plasma deproteinized with acetonitrile (final conc 80& v/v) containing 25ug Nor and 10ug C4-D7. Vortex. Incubate 20min at RT and centrifuge. Evaporate SN under N2 at 50deg resuspend in150ul methanol.,100.0,Acetonitrile,N2,Methanol,,,HPLC-MS/MS,2020,Arithmetic Mean,,HPLC-MS/MS,71.0
71,Distinct Postprandial Bile Acids Responses to a High-Calorie Diet in Men Volunteers Underscore Metabolically Healthy and Unhealthy Phenotypes,https://doi.org/10.3390/nu12113545,Plasma,71,Normal,Fed,LC-MS,uM,240.0,400.0,340.0,52.0,29.0,130.0,1030.0,270.0,,,52.0,190.0,150.0,,,422.0,1620.0,760.0,,,1.717247879,0.411851126,,,Healthy,Normal,Normal,71.0,0.0,30.1,100ul plasma deproteinized with acetonitrile (final conc 80& v/v) containing 25ug Nor and 10ug C4-D7. Vortex. Incubate 20min at RT and centrifuge. Evaporate SN under N2 at 50deg resuspend in150ul methanol.,100.0,Acetonitrile,N2,Methanol,,,HPLC-MS/MS,2020,Arithmetic Mean,,HPLC-MS/MS,71.0
72,Divergent effects of resistance and endurance exercise on plasma bile acids; FGF19; and FGF21 in humans,https://doi.org/10.1172/jci.insight.122737,Serum,10,Normal,Fasted,LC-MS,uM,220.0,360.0,90.0,60.0,10.0,160.0,290.0,150.0,90.0,,20.0,150.0,,,,400.0,800.0,240.0,150.0,,1.162162162,0.333333333,,,Healthy,Normal,Normal,10.0,0.0,24.0,150ul plasma with 10ul IS. 525ul ice-cold LC-MS MeOH added. Centrifuge. SN dried via speed vacuum. Samples resuspended in 50ul 95/5  5nM ammonium acetate with 0.1% formic acid/0.1% formic acid in acetonitrile.  ,150.0,Methanol,Vacuum,Ammonium Acetate:Formic Acid:Acetonitrile,,,LC-MS,2018,Arithmetic Mean,,LC-MS: Arithmetic Mean; Before Endurance Exercise,10.0
73,Divergent effects of resistance and endurance exercise on plasma bile acids; FGF19; and FGF21 in humans,https://doi.org/10.1172/jci.insight.122737,Serum,10,Normal,Fasted,LC-MS,uM,180.0,280.0,80.0,60.0,20.0,110.0,130.0,160.0,50.0,,30.0,180.0,,,,320.0,590.0,240.0,100.0,,1.064516129,0.406593407,,,Healthy,Normal,Normal,10.0,0.0,24.0,150ul plasma with 10ul IS. 525ul ice-cold LC-MS MeOH added. Centrifuge. SN dried via speed vacuum. Samples resuspended in 50ul 95/5  5nM ammonium acetate with 0.1% formic acid/0.1% formic acid in acetonitrile.  ,150.0,Methanol,Vacuum,Ammonium Acetate:Formic Acid:Acetonitrile,,,LC-MS,2018,Arithmetic Mean,,LC-MS: Arithmetic Mean; After Endurance Exercise,10.0
74,Divergent effects of resistance and endurance exercise on plasma bile acids; FGF19; and FGF21 in humans,https://doi.org/10.1172/jci.insight.122737,Serum,10,Normal,Fasted,LC-MS,uM,210.0,360.0,140.0,60.0,30.0,100.0,470.0,130.0,30.0,,120.0,80.0,,,,420.0,900.0,270.0,100.0,,1.1625,0.291044776,,,Healthy,Normal,Normal,10.0,0.0,24.0,150ul plasma with 10ul IS. 525ul ice-cold LC-MS MeOH added. Centrifuge. SN dried via speed vacuum. Samples resuspended in 50ul 95/5  5nM ammonium acetate with 0.1% formic acid/0.1% formic acid in acetonitrile.  ,150.0,Methanol,Vacuum,Ammonium Acetate:Formic Acid:Acetonitrile,,,LC-MS,2018,Arithmetic Mean,,LC-MS: Arithmetic Mean; 60 mins after Endurance Exercise,10.0
75,Divergent effects of resistance and endurance exercise on plasma bile acids; FGF19; and FGF21 in humans,https://doi.org/10.1172/jci.insight.122737,Serum,10,Normal,Fasted,LC-MS,uM,40.0,120.0,100.0,40.0,20.0,90.0,290.0,80.0,20.0,,90.0,70.0,,,,230.0,490.0,180.0,60.0,,2.0,0.371428571,,,Healthy,Normal,Normal,10.0,0.0,24.0,150ul plasma with 10ul IS. 525ul ice-cold LC-MS MeOH added. Centrifuge. SN dried via speed vacuum. Samples resuspended in 50ul 95/5  5nM ammonium acetate with 0.1% formic acid/0.1% formic acid in acetonitrile.  ,150.0,Methanol,Vacuum,Ammonium Acetate:Formic Acid:Acetonitrile,,,LC-MS,2018,Arithmetic Mean,,LC-MS: Arithmetic Mean; 180 mins after Endurance Exercise,10.0
76,Divergent effects of resistance and endurance exercise on plasma bile acids; FGF19; and FGF21 in humans,https://doi.org/10.1172/jci.insight.122737,Serum,10,Normal,Fasted,LC-MS,uM,650.0,640.0,130.0,160.0,10.0,160.0,170.0,170.0,120.0,,20.0,150.0,,,,830.0,960.0,300.0,270.0,,0.496855346,0.329608939,,,Healthy,Normal,Normal,10.0,0.0,24.0,150ul plasma with 10ul IS. 525ul ice-cold LC-MS MeOH added. Centrifuge. SN dried via speed vacuum. Samples resuspended in 50ul 95/5  5nM ammonium acetate with 0.1% formic acid/0.1% formic acid in acetonitrile.  ,150.0,Methanol,Vacuum,Ammonium Acetate:Formic Acid:Acetonitrile,,,LC-MS,2018,Arithmetic Mean,,LC-MS: Arithmetic Mean; Before  Resistance Exercise,10.0
77,Divergent effects of resistance and endurance exercise on plasma bile acids; FGF19; and FGF21 in humans,https://doi.org/10.1172/jci.insight.122737,Serum,10,Normal,Fasted,LC-MS,uM,430.0,430.0,100.0,90.0,20.0,130.0,250.0,120.0,50.0,,20.0,130.0,,,,580.0,800.0,220.0,140.0,,0.654205607,0.273381295,,,Healthy,Normal,Normal,10.0,0.0,24.0,150ul plasma with 10ul IS. 525ul ice-cold LC-MS MeOH added. Centrifuge. SN dried via speed vacuum. Samples resuspended in 50ul 95/5  5nM ammonium acetate with 0.1% formic acid/0.1% formic acid in acetonitrile.  ,150.0,Methanol,Vacuum,Ammonium Acetate:Formic Acid:Acetonitrile,,,LC-MS,2018,Arithmetic Mean,,LC-MS: Arithmetic Mean; After Resistance Exercise,10.0
78,Divergent effects of resistance and endurance exercise on plasma bile acids; FGF19; and FGF21 in humans,https://doi.org/10.1172/jci.insight.122737,Serum,10,Normal,Fasted,LC-MS,uM,200.0,290.0,150.0,50.0,30.0,130.0,340.0,120.0,20.0,,140.0,80.0,,,,470.0,700.0,270.0,80.0,,1.152777778,0.313559322,,,Healthy,Normal,Normal,10.0,0.0,24.0,150ul plasma with 10ul IS. 525ul ice-cold LC-MS MeOH added. Centrifuge. SN dried via speed vacuum. Samples resuspended in 50ul 95/5  5nM ammonium acetate with 0.1% formic acid/0.1% formic acid in acetonitrile.  ,150.0,Methanol,Vacuum,Ammonium Acetate:Formic Acid:Acetonitrile,,,LC-MS,2018,Arithmetic Mean,,LC-MS: Arithmetic Mean; 60 mins after Resistance Exercise,10.0
79,Divergent effects of resistance and endurance exercise on plasma bile acids; FGF19; and FGF21 in humans,https://doi.org/10.1172/jci.insight.122737,Serum,10,Normal,Fasted,LC-MS,uM,200.0,310.0,140.0,50.0,30.0,100.0,300.0,80.0,20.0,,90.0,70.0,,,,400.0,680.0,220.0,60.0,,0.904109589,0.299065421,,,Healthy,Normal,Normal,10.0,0.0,24.0,150ul plasma with 10ul IS. 525ul ice-cold LC-MS MeOH added. Centrifuge. SN dried via speed vacuum. Samples resuspended in 50ul 95/5  5nM ammonium acetate with 0.1% formic acid/0.1% formic acid in acetonitrile.  ,150.0,Methanol,Vacuum,Ammonium Acetate:Formic Acid:Acetonitrile,,,LC-MS,2018,Arithmetic Mean,,LC-MS: Arithmetic Mean; 180 mins after Resistance Exercise,10.0
80,Early Increases in Bile Acids Post Roux-en-Y Gastric Bypass Are Driven by Insulin-Sensitizing; Secondary Bile Acids,https://doi.org/10.1210/jc.2015-2467,Plasma,20,Normal,Fasted,LC-MS,nM,35.02,49.77,104.83,31.96,,,,106.21,48.05,,,,,0.3608,,,,,80.3708,,0.697810272,3.436853403,,,Healthy,Normal,Normal,3.0,18.0,,50ul plasma. 200ul 100nM NaOH and 50ul IS. Heated to 64deg for 30min. Centrifuge. SN acidified to pH 7 with 50ul 0.1M hydrochloric acid. Bring to final volume 1ml water. Added to colum equilibrated with 1ml MeOH; 1ml H2O. BAs washed with 1ml 5% aqueous methanol; 1ml 2% aq formic acid. BAs eluted with 1ml 2% ammonia in methanol. Evaporated to dryness using a rotary evaporator at 30deg for 2h. Resuspended in 100ul 25% acetonitrile in H2O,50.0,Sodium Hydroxide,Vacuum,Acetonitrile:H2O,SPE,,UPLC-ESI-MS,2015,Arithmetic Mean,,UPLC-ESI-MS: Mean; Pre Surgery,21.0
81,Early Increases in Bile Acids Post Roux-en-Y Gastric Bypass Are Driven by Insulin-Sensitizing; Secondary Bile Acids,https://doi.org/10.1210/jc.2015-2467,Plasma,20,Unhealthy,Fasted,LC-MS,nM,36.73,61.43,149.66,110.5,,,,68.37,327.63,,,,,1.73,,,,,,,1.109985488,6.702220864,,,,,,3.0,18.0,,50ul plasma. 200ul 100nM NaOH and 50ul IS. Heated to 64deg for 30min. Centrifuge. SN acidified to pH 7 with 50ul 0.1M hydrochloric acid. Bring to final volume 1ml water. Added to colum equilibrated with 1ml MeOH; 1ml H2O. BAs washed with 1ml 5% aqueous methanol; 1ml 2% aq formic acid. BAs eluted with 1ml 2% ammonia in methanol. Evaporated to dryness using a rotary evaporator at 30deg for 2h. Resuspended in 100ul 25% acetonitrile in H2O,50.0,Sodium Hydroxide,Vacuum,Acetonitrile:H2O,SPE,,UPLC-ESI-MS,2015,Arithmetic Mean,,UPLC-ESI-MS: Mean; 1 mo post RYGB,21.0
82,Early Increases in Bile Acids Post Roux-en-Y Gastric Bypass Are Driven by Insulin-Sensitizing; Secondary Bile Acids,https://doi.org/10.1210/jc.2015-2467,Plasma,20,Unhealthy,Fasted,LC-MS,nM,42.17,57.34,146.94,32.42,,,,121.43,134.7,,,,,0.65,,,,,,,0.920787464,4.382876093,,,,,,3.0,18.0,,50ul plasma. 200ul 100nM NaOH and 50ul IS. Heated to 64deg for 30min. Centrifuge. SN acidified to pH 7 with 50ul 0.1M hydrochloric acid. Bring to final volume 1ml water. Added to colum equilibrated with 1ml MeOH; 1ml H2O. BAs washed with 1ml 5% aqueous methanol; 1ml 2% aq formic acid. BAs eluted with 1ml 2% ammonia in methanol. Evaporated to dryness using a rotary evaporator at 30deg for 2h. Resuspended in 100ul 25% acetonitrile in H2O,50.0,Sodium Hydroxide,Vacuum,Acetonitrile:H2O,SPE,,UPLC-ESI-MS,2015,Arithmetic Mean,,UPLC-ESI-MS: Mean; 6 mo post RYGB,21.0
83,Early Increases in Bile Acids Post Roux-en-Y Gastric Bypass Are Driven by Insulin-Sensitizing; Secondary Bile Acids,https://doi.org/10.1210/jc.2015-2467,Plasma,20,Unhealthy,Fasted,LC-MS,nM,31.29,116.72,155.1,6.85,,,,191.84,31.96,,,,,0.46,,,,,,,0.723512711,2.60935072,,,,,,3.0,18.0,,50ul plasma. 200ul 100nM NaOH and 50ul IS. Heated to 64deg for 30min. Centrifuge. SN acidified to pH 7 with 50ul 0.1M hydrochloric acid. Bring to final volume 1ml water. Added to colum equilibrated with 1ml MeOH; 1ml H2O. BAs washed with 1ml 5% aqueous methanol; 1ml 2% aq formic acid. BAs eluted with 1ml 2% ammonia in methanol. Evaporated to dryness using a rotary evaporator at 30deg for 2h. Resuspended in 100ul 25% acetonitrile in H2O,50.0,Sodium Hydroxide,Vacuum,Acetonitrile:H2O,SPE,,UPLC-ESI-MS,2015,Arithmetic Mean,,UPLC-ESI-MS: Mean; 12 mo post RYGB,21.0
84,Early Increases in Bile Acids Post Roux-en-Y Gastric Bypass Are Driven by Insulin-Sensitizing; Secondary Bile Acids,https://doi.org/10.1210/jc.2015-2467,Plasma,20,Unhealthy,Fasted,LC-MS,nM,144.22,258.02,269.39,26.48,,,,214.29,38.81,,,,,0.43,,,,,,,0.363166263,1.365851233,,,,,,3.0,18.0,,50ul plasma. 200ul 100nM NaOH and 50ul IS. Heated to 64deg for 30min. Centrifuge. SN acidified to pH 7 with 50ul 0.1M hydrochloric acid. Bring to final volume 1ml water. Added to colum equilibrated with 1ml MeOH; 1ml H2O. BAs washed with 1ml 5% aqueous methanol; 1ml 2% aq formic acid. BAs eluted with 1ml 2% ammonia in methanol. Evaporated to dryness using a rotary evaporator at 30deg for 2h. Resuspended in 100ul 25% acetonitrile in H2O,50.0,Sodium Hydroxide,Vacuum,Acetonitrile:H2O,SPE,,UPLC-ESI-MS,2015,Arithmetic Mean,,UPLC-ESI-MS: Mean; 24 mo post RYGB,21.0
85,Efficacy of bile acid profiles in diagnosing and staging of alcoholic liver disease.,https://doi.org/10.1080/00365513.2022.2151508,Serum,40,Unhealthy,Fasted,LC-MS,nM,1397.6,3365.4,507.8,4867.1,131.7,10051.0,29792.3,1061.3,25009.1,186.1,3521.2,8592.3,256.4,3997.6,72.5,14969.8,41750.0,1825.5,33873.8,390.3,8.037294539,0.636278689,Cirrhosis,,Liver,Cirrhosis,Metabolic,40.0,0.0,55.9,50ul serum. 150ul MeOH acetonitrile 50% added. Vortex. -20deg for 30min. Centrifuge. 100ul SN collected for analysis,100.0,Methanol:Acetonitrile,N2,,,,UHPLC-TQ-TOFMS,2022,Arithmetic Mean,3.85,UHPLC-TQ-TOFMS: Mean; Cirrhosis,40.0
86,Efficacy of bile acid profiles in diagnosing and staging of alcoholic liver disease.,https://doi.org/10.1080/00365513.2022.2151508,Serum,45,Unhealthy,Fasted,LC-MS,nM,352.6,726.0,193.5,143.8,10.4,1151.8,3713.6,176.3,262.4,10.2,334.2,1053.1,45.6,12.1,3.6,1838.6,5492.7,415.4,418.3,24.2,4.741569095,0.11701881,ALD,,Liver,,,45.0,0.0,52.6,50ul serum. 150ul MeOH acetonitrile 50% added. Vortex. -20deg for 30min. Centrifuge. 100ul SN collected for analysis,100.0,Methanol:Acetonitrile,N2,,,,UHPLC-TQ-TOFMS,2022,Arithmetic Mean,1.12,UHPLC-TQ-TOFMS: Mean; ALD,45.0
87,Efficacy of bile acid profiles in diagnosing and staging of alcoholic liver disease.,https://doi.org/10.1080/00365513.2022.2151508,Serum,42,Unhealthy,Fasted,LC-MS,nM,214.9,461.1,390.3,108.7,19.8,468.2,1090.5,305.1,115.6,22.4,125.8,290.8,57.0,10.0,4.6,808.9,1842.4,752.4,234.3,46.8,2.0840308,0.389808773,Viral Liver Disease,,Liver,,,16.0,26.0,48.1,50ul serum. 150ul MeOH acetonitrile 50% added. Vortex. -20deg for 30min. Centrifuge. 100ul SN collected for analysis,100.0,Methanol:Acetonitrile,N2,,,,UHPLC-TQ-TOFMS,2022,Arithmetic Mean,0.96,UHPLC-TQ-TOFMS: Mean; Viral Liver Disease,42.0
88,Efficacy of bile acid profiles in diagnosing and staging of alcoholic liver disease.,https://doi.org/10.1080/00365513.2022.2151508,Serum,40,Normal,Fasted,LC-MS,nM,98.5,243.0,273.7,61.2,12.4,166.2,609.6,192.2,85.1,10.0,17.8,56.9,22.6,3.8,2.6,282.5,909.5,488.5,150.1,25.0,1.693960511,0.556711409,,,Healthy,Normal,Normal,19.0,21.0,39.0,50ul serum. 150ul MeOH acetonitrile 50% added. Vortex. -20deg for 30min. Centrifuge. 100ul SN collected for analysis,100.0,Methanol:Acetonitrile,N2,,,,UHPLC-TQ-TOFMS,2022,Arithmetic Mean,0.95,UHPLC-TQ-TOFMS: Mean; Healthy,40.0
89,Efficacy of bile acid profiles in diagnosing and staging of alcoholic liver disease.,https://doi.org/10.1080/00365513.2022.2151508,Serum,41,Unhealthy,Fasted,LC-MS,nM,285.2,658.7,211.9,121.9,6.5,282.7,862.5,65.8,84.1,4.7,48.3,97.1,12.1,4.3,2.5,616.2,1618.3,289.8,210.3,13.7,1.140087214,0.229939584,NAFLD,,Liver,NAFLD,Metabolic,19.0,22.0,39.8,50ul serum. 150ul MeOH acetonitrile 50% added. Vortex. -20deg for 30min. Centrifuge. 100ul SN collected for analysis,100.0,Methanol:Acetonitrile,N2,,,,UHPLC-TQ-TOFMS,2022,Arithmetic Mean,1.04,UHPLC-TQ-TOFMS: Mean; NAFLD,41.0
90,Elevated hepatic fatty acid oxidation; high plasma fibroblast growth factor 21; and fasting bile acids in nonalcoholic steatohepatitis,https://doi.org/10.1097/MEG.0b013e328345c8c7,Plasma,38,Normal,Fasted,LC-MS,ng/ml,,,,,,0.5798969072164949,,,,,0.09695559433779329,0.4002401440864519,,,,,,,,,,,,,Healthy,Normal,Normal,,,,250ul plasma mixed with 800ul acetonitrile. Vortex and centrifuge. SN blown to dryness with N2. Reconstituted in 125ul methanol and 125ul water.,250.0,Acetonitrile,N2,Methanol:H2O,,,HPLC-MS/MS,2011,Arithmetic Mean,,HPLC-MS/MS: Mean,
91,Elevated hepatic fatty acid oxidation; high plasma fibroblast growth factor 21; and fasting bile acids in nonalcoholic steatohepatitis,https://doi.org/10.1097/MEG.0b013e328345c8c7,Plasma,36,Unhealthy,Fasted,LC-MS,ng/ml,,,,,,2.663230240549828,,,,,0.4459957339538491,1.5609365619371625,,,,,,,,,,,,,Liver,NASH,Metabolic,,,,250ul plasma mixed with 800ul acetonitrile. Vortex and centrifuge. SN blown to dryness with N2. Reconstituted in 125ul methanol and 125ul water.,250.0,Acetonitrile,N2,Methanol:H2O,,,HPLC-MS/MS,2011,Arithmetic Mean,,HPLC-MS/MS: Mean; NASH,
92,Exercise training and diet-induced weight loss increase markers of hepatic bile acid (BA) synthesis and reduce serum total BA concentrations in obese women,https://doi.org/10.1152/ajpendo.00644.2020,Serum,11,Normal,Fasted,LC-MS,uM,20.0,70.0,140.0,10.0,,120.0,350.0,120.0,40.0,,10.0,30.0,20.0,2.0,,150.0,450.0,280.0,52.0,,2.883333333,0.553333333,Obese,,Healthy,Normal,Normal,0.0,11.0,,50ul serum. 325ul 1/100 dilution IS solution. 225ul cold MeOH added for protein precipitation. Vortex. Kept at -20deg for 20mins; Centrifuge. SN dried in Savant speedvac concentrator. Reconsititute in 50ul MeOH:H20 50:50 v/v. Centrifuge,50.0,Methanol,Vacuum,Methanol:H2O,,,UPLC-MS,2021,Median,,UPLC-MS: Median; Pre-exercise intervention,11.0
93,Exercise training and diet-induced weight loss increase markers of hepatic bile acid (BA) synthesis and reduce serum total BA concentrations in obese women,https://doi.org/10.1152/ajpendo.00644.2020,Serum,11,Normal,Fasted,LC-MS,uM,30.0,60.0,110.0,10.0,,80.0,320.0,60.0,30.0,,10.0,30.0,10.0,1.0,,120.0,410.0,180.0,41.0,,2.576190476,0.416981132,Obese,,Healthy,Normal,Normal,0.0,11.0,,50ul serum. 325ul 1/100 dilution IS solution. 225ul cold MeOH added for protein precipitation. Vortex. Kept at -20deg for 20mins; Centrifuge. SN dried in Savant speedvac concentrator. Reconsititute in 50ul MeOH:H20 50:50 v/v. Centrifuge,50.0,Methanol,Vacuum,Methanol:H2O,,,UPLC-MS,2021,Median,,UPLC-MS: Median; Post-exercise intervention,11.0
94,Fasting serum bile acids concentration is associated with insulin resistance independently of diabetes status ,https://doi.org/10.1515/cclm-2018-0741,Serum,75,Normal,Fasted,LC-MS,uM,98.7,266.0,283.0,56.2,21.8,150.0,770.0,210.0,81.5,8.9,19.5,62.5,22.9,9.5,3.7,268.2,1098.5,515.9,147.2,34.4,1.844426071,0.510353406,,,Healthy,Normal,Normal,28.0,47.0,33.0,10ul serum added to 10ul IS mixture. Nitrogen drying. 100ul MeOH. Centrifuge to elute MeOH extract. 60ul deionized H2O to extract.,10.0,,,Methanol:H2O,,,HPLC-MS/MS,2019,Median,,HPLC-MS/MS: Median; Normal,75.0
95,Fasting serum bile acids concentration is associated with insulin resistance independently of diabetes status ,https://doi.org/10.1515/cclm-2018-0741,Serum,71,Normal,Fasted,LC-MS,uM,71.7,170.0,274.0,38.800000000000004,21.1,102.0,487.0,119.0,58.0,7.1000000000000005,28.8,58.3,21.8,9.2,3.8,202.5,715.3000000000001,414.8,106.0,32.0,1.554899236,0.602309871,,,Healthy,Normal,Normal,43.0,28.0,55.0,10ul serum added to 10ul IS mixture. Nitrogen drying. 100ul MeOH. Centrifuge to elute MeOH extract. 60ul deionized H2O to extract.,10.0,,,Methanol:H2O,,,HPLC-MS/MS,2019,Median,,HPLC-MS/MS: Median; T2DM,71.0
96,Fasting serum bile acids concentration is associated with insulin resistance independently of diabetes status ,https://doi.org/10.1515/cclm-2018-0741,Serum,95,Normal,Fasted,LC-MS,uM,90.5,204.0,292.0,46.5,15.4,113.0,488.0,165.0,65.4,7.6,19.900000000000002,50.6,18.2,10.5,3.5,223.39999999999998,742.6,475.2,122.39999999999999,26.5,1.452344232,0.646066253,,,Healthy,Normal,Normal,40.0,55.0,55.0,10ul serum added to 10ul IS mixture. Nitrogen drying. 100ul MeOH. Centrifuge to elute MeOH extract. 60ul deionized H2O to extract.,10.0,,,Methanol:H2O,,,HPLC-MS/MS,2019,Median,,HPLC-MS/MS: Median; Impaired fasting glucose,95.0
97,Fasting Serum Taurine-Conjugated Bile Acids Are Elevated in Type 2 Diabetes and Do Not Change With Intensification of Insulin,https://doi.org/10.1210/jc.2013-3367,Serum,12,Normal,Fasted,LC-MS,uM,99.0,,,223.0,,664.0,,,150.0,,213.0,,,14.0,,976.0,,,,,3.232919255,0.396516393,T2D,,Healthy,Normal,Normal,4.0,8.0,49.0,50ul serum. 50ul IS and 400ul acetonitrile. Centrifugation. Dried. Reconstituted in 400ul methanol and 200ul H2O.,50.0,Acetonitrile,,Methanol:H2O,,,HPLC-MS/MS,2014,Arithmetic Mean,,HPLC-MS/MS: Mean; T2D; Fasted,12.0
98,Fasting Serum Taurine-Conjugated Bile Acids Are Elevated in Type 2 Diabetes and Do Not Change With Intensification of Insulin,https://doi.org/10.1210/jc.2013-3367,Serum,62,Normal,Fed,LC-MS,uM,75.0,,,150.0,,257.0,,,88.0,,24.0,,,0.3,,356.0,,,,,1.641333333,0.669382022,,,Healthy,Normal,Normal,28.0,34.0,40.0,50ul serum. 50ul IS and 400ul acetonitrile. Centrifugation. Dried. Reconstituted in 400ul methanol and 200ul H2O.,50.0,Acetonitrile,,Methanol:H2O,,,HPLC-MS/MS,2014,Arithmetic Mean,,HPLC-MS/MS: Mean; Healthy Control; Fed,62.0
99,Fasting Serum Taurine-Conjugated Bile Acids Are Elevated in Type 2 Diabetes and Do Not Change With Intensification of Insulin,https://doi.org/10.1210/jc.2013-3367,Serum,25,Normal,Fed,LC-MS,uM,167.0,,,143.0,,233.0,,,85.0,,31.0,,,2.0,,431.0,,,,,1.132258065,0.533642691,IGT,,Healthy,Normal,Normal,6.0,19.0,45.0,50ul serum. 50ul IS and 400ul acetonitrile. Centrifugation. Dried. Reconstituted in 400ul methanol and 200ul H2O.,50.0,Acetonitrile,,Methanol:H2O,,,HPLC-MS/MS,2014,Arithmetic Mean,,HPLC-MS/MS: Mean; IGT; Fed,25.0
100,Fasting Serum Taurine-Conjugated Bile Acids Are Elevated in Type 2 Diabetes and Do Not Change With Intensification of Insulin,https://doi.org/10.1210/jc.2013-3367,Serum,12,Normal,Fed,LC-MS,uM,567.0,,,188.0,,592.0,,,77.0,,131.0,,,3.0,,1290.0,,,,,1.063576159,0.207751938,T2D,,Healthy,Normal,Normal,4.0,8.0,49.0,50ul serum. 50ul IS and 400ul acetonitrile. Centrifugation. Dried. Reconstituted in 400ul methanol and 200ul H2O.,50.0,Acetonitrile,,Methanol:H2O,,,HPLC-MS/MS,2014,Arithmetic Mean,,HPLC-MS/MS: Mean; T2D; Fed,12.0
101,Fasting Serum Taurine-Conjugated Bile Acids Are Elevated in Type 2 Diabetes and Do Not Change With Intensification of Insulin,https://doi.org/10.1210/jc.2013-3367,Serum,62,Normal,Fasted,LC-MS,uM,161.0,,,193.0,,168.0,,,112.0,,36.0,,,2.0,,365.0,,,,,0.898305085,0.84109589,,,Healthy,Normal,Normal,28.0,34.0,40.0,50ul serum. 50ul IS and 400ul acetonitrile. Centrifugation. Dried. Reconstituted in 400ul methanol and 200ul H2O.,50.0,Acetonitrile,,Methanol:H2O,,,HPLC-MS/MS,2014,Arithmetic Mean,,HPLC-MS/MS: Mean; Healthy Control; Fasted,62.0
102,Fasting Serum Taurine-Conjugated Bile Acids Are Elevated in Type 2 Diabetes and Do Not Change With Intensification of Insulin,https://doi.org/10.1210/jc.2013-3367,Serum,25,Normal,Fasted,LC-MS,uM,270.0,,,193.0,,209.0,,,127.0,,48.0,,,6.0,,527.0,,,,,0.842332613,0.618595825,IGT,,Healthy,Normal,Normal,6.0,19.0,45.0,50ul serum. 50ul IS and 400ul acetonitrile. Centrifugation. Dried. Reconstituted in 400ul methanol and 200ul H2O.,50.0,Acetonitrile,,Methanol:H2O,,,HPLC-MS/MS,2014,Arithmetic Mean,,HPLC-MS/MS: Mean; IGT; Fasted,25.0
103,Hepatic Uptake of Bile Acids in Man,https://doi.org/10.1172/JCI110668,Serum,5,Unhealthy,Fasted,GC-MS,uM,,,,,,,,,,,,,,,,610.0,640.0,1190.0,,,,,Cholecystectomised,,Non-Liver,,,1.0,4.0,62.0,1ml serum. Hydrolysis with 1M KOH at 110deg for 12h. Alkaline solution ectracted 3 times with ethyl ether. BAs extracted from acidified water phase with ethyl ether. Methylated with diazomethane and converted into trimethylsilyl ether. LKB 9000 Instrument and 1.5% SE-30 column,1000.0,,,,,,GC-MS,1982,Arithmetic Mean,,GC-MS: Arithmetic Mean,5.0
104,Human insulin resistance is associated with increased plasma levels of 12-alpha hydroxylated bile acids.,https://doi.org/10.2337/db13-0639,Plasma,35,Normal,Fasted,LC-MS,uM,40.0,170.0,330.0,50.0,10.0,150.0,570.0,190.0,,,40.0,60.0,30.0,,,230.0,800.0,550.0,,,1.733333333,0.59223301,T2D,,Healthy,Normal,Normal,17.0,18.0,53.0,100ul plasma. Spiked with 10ul IS. Mixed with 1ml ice-cold acetonitrile. Vortex. Centrifuge. SN dried at 45deg under N2. Reconstitute in 100ul 55/45 MeOH/H2O; containing 5mM ammonium formate,100.0,Acetonitrile,N2,Methanol:H2O,,,HPLC-MS,2013,Arithmetic Mean,,HPLC-MS: Mean; T2D,35.0
105,Human insulin resistance is associated with increased plasma levels of 12-alpha hydroxylated bile acids.,https://doi.org/10.2337/db13-0639,Plasma,200,Normal,Fasted,LC-MS,uM,50.0,90.0,200.0,20.0,10.0,80.0,310.0,100.0,,,10.0,30.0,20.0,,,140.0,430.0,320.0,,,1.486486486,0.614035088,,,Healthy,Normal,Normal,97.0,103.0,46.0,100ul plasma. Spiked with 10ul IS. Mixed with 1ml ice-cold acetonitrile. Vortex. Centrifuge. SN dried at 45deg under N2. Reconstitute in 100ul 55/45 MeOH/H2O; containing 5mM ammonium formate,100.0,Acetonitrile,N2,Methanol:H2O,,,HPLC-MS,2013,Arithmetic Mean,,HPLC-MS,200.0
106,In Search of an Accurate Evaluation of Intrahepatic Cholestasis of Pregnancy,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3820586/,Serum,23,Normal,Fasted,Capillary Electrophoresis,uM,,,,,,,,,,,,,,,,400.0,750.0,1900.0,3100.0,340.0,,,,,,Normal,Normal,0.0,23.0,,2ml serum. Add 3ml acetonitrile. Vortex. 0.5g ammonium sulphate to SN. Organic phases evaporated and redissolved in 300ul acetonitrile. 6.7ml water added. 7ml volume passed through C18 Bakerbond cartridge condtioned with 4ml methanol and 5ml water. BAs eluted with 4ml methanol. Eluate evaporated to dryness and dissolved in 50ul 1mM sodium borate; 1mM sodium dihydrogen phosphate; pH 7.0 in 20% MeOH. ,2000.0,,,,,,Capillary Electrophoresis,2012,Arithmetic Mean,,Capillary Electrophoresis: Mean; Healthy Control,23.0
107,In Search of an Accurate Evaluation of Intrahepatic Cholestasis of Pregnancy,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3820586/,Serum,15,Unhealthy,Fasted,Capillary Electrophoresis,uM,,,,,,,,,,,,,,,,1100.0,1300.0,5600.0,10800.0,600.0,,,Asymptomatic Hypercholanemia of Pregnancy,,,,,0.0,15.0,,2ml serum. Add 3ml acetonitrile. Vortex. 0.5g ammonium sulphate to SN. Organic phases evaporated and redissolved in 300ul acetonitrile. 6.7ml water added. 7ml volume passed through C18 Bakerbond cartridge condtioned with 4ml methanol and 5ml water. BAs eluted with 4ml methanol. Eluate evaporated to dryness and dissolved in 50ul 1mM sodium borate; 1mM sodium dihydrogen phosphate; pH 7.0 in 20% MeOH. ,2000.0,,,,,,Capillary Electrophoresis,2012,Arithmetic Mean,0.4,Capillary Electrophoresis: Mean; Asymptomatic Hypercholanemia of Pregnancy ,15.0
108,In Search of an Accurate Evaluation of Intrahepatic Cholestasis of Pregnancy,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3820586/,Serum,9,Unhealthy,Fasted,Capillary Electrophoresis,uM,,,,,,,,,,,,,,,,8800.0,1800.0,6000.0,1100.0,6500.0,,,Intrahepatic Cholestasis Low,,Liver,Cholestasis,Cholestasis,0.0,9.0,31.0,2ml serum. Add 3ml acetonitrile. Vortex. 0.5g ammonium sulphate to SN. Organic phases evaporated and redissolved in 300ul acetonitrile. 6.7ml water added. 7ml volume passed through C18 Bakerbond cartridge condtioned with 4ml methanol and 5ml water. BAs eluted with 4ml methanol. Eluate evaporated to dryness and dissolved in 50ul 1mM sodium borate; 1mM sodium dihydrogen phosphate; pH 7.0 in 20% MeOH. ,2000.0,,,,,,Capillary Electrophoresis,2012,Arithmetic Mean,0.4,Capillary Electrophoresis: Mean; Intrahepatic Cholestasis Low (Pruritus score),9.0
109,In Search of an Accurate Evaluation of Intrahepatic Cholestasis of Pregnancy,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3820586/,Serum,23,Unhealthy,Fasted,Capillary Electrophoresis,uM,,,,,,,,,,,,,,,,7100.0,10400.0,12000.0,5200.0,20300.0,,,Intrahepatic Cholestasis High,,Liver,Cholestasis,Cholestasis,0.0,23.0,27.0,2ml serum. Add 3ml acetonitrile. Vortex. 0.5g ammonium sulphate to SN. Organic phases evaporated and redissolved in 300ul acetonitrile. 6.7ml water added. 7ml volume passed through C18 Bakerbond cartridge condtioned with 4ml methanol and 5ml water. BAs eluted with 4ml methanol. Eluate evaporated to dryness and dissolved in 50ul 1mM sodium borate; 1mM sodium dihydrogen phosphate; pH 7.0 in 20% MeOH. ,2000.0,,,,,,Capillary Electrophoresis,2012,Arithmetic Mean,0.83,Capillary Electrophoresis: Mean; Intrahepatic Cholestasis High (Pruritus score),23.0
110,Individual bile acids in portal venous and systemic blood serum of fasting man,https://doi.org/10.1016/S0016-5085(19)31517-3,Serum,10,Unhealthy,Fasted,GC-MS,uM,,,,,,,,,,,,,,,,490.0,1550.0,1440.0,,,,,Cholelithiasis,,Non-Liver,,,3.0,7.0,61.0,1ml serum. Hydrolysis with 1M KOH at 110deg for 12h. Alkaline solution ectracted 3 times with ethyl ether. BAs extracted from acidified water phase with ethyl ether. Methylated with diazomethane and converted into trimethylsilyl ether. LKB 9000 Instrument and 1.5% SE-30 column,1000.0,,,,,,GC-MS,1977,Arithmetic Mean,0.47,GC-MS: Mean; Cholelithiasis,10.0
111,Influence of Roux-en-Y gastric bypass on plasma bile acid profiles: a comparative study between rats; pigs and humans,https://doi.org/10.1038/ijo.2016.46,Plasma,7,Normal,Fasted,LC-MS,uM,230.0,254.0,335.0,80.10000000000001,,177.0,602.0,170.0,102.0,15.6,35.9,59.8,27.5,,,442.90000000000003,915.8,532.5,,,1.323323323,0.53742548,Pre-RYGB Surgery,,Non-Liver,,,1.0,6.0,29.0,50ul serum. 325ul 1/100 dilution IS solution. 225ul cold MeOH added for protein precipitation. Vortex. Kept at -20deg for 20mins; Centrifuge. SN dried in Savant speedvac concentrator. Reconsititute in 50ul MeOH:H20 50:50 v/v. Centrifuge,50.0,Methanol,Vacuum,Methanol:H2O,,,HPLC-MS/MS,2016,Arithmetic Mean,,HPLC-MS/MS: Mean;Pre RYGB surgery,7.0
112,Influence of Roux-en-Y gastric bypass on plasma bile acid profiles: a comparative study between rats; pigs and humans,https://doi.org/10.1038/ijo.2016.46,Plasma,7,Unhealthy,Fasted,LC-MS,uM,2150.0,1620.0,1200.0,207.0,,212.0,619.0,232.0,71.8,12.0,22.700000000000003,62.199999999999996,31.099999999999998,,,2384.7,2301.2000000000003,1463.1000000000001,,,0.243925053,0.374293092,Post-RYGB Surgery,,Non-Liver,,,1.0,6.0,29.0,50ul serum. 325ul 1/100 dilution IS solution. 225ul cold MeOH added for protein precipitation. Vortex. Kept at -20deg for 20mins; Centrifuge. SN dried in Savant speedvac concentrator. Reconsititute in 50ul MeOH:H20 50:50 v/v. Centrifuge,50.0,Methanol,Vacuum,Methanol:H2O,,,HPLC-MS/MS,2016,Arithmetic Mean,,HPLC-MS/MS: Mean;Post RYGB surgery,7.0
113,Longitudinal Profiles of 15 Serum Bile Acids in Patients With Intrahepatic Cholestasis of Pregnancy,https://doi.org/10.1038/ajg.2009.633,Serum,50,Unhealthy,Fed,LC-MS,uM,600.0,140.0,100.0,15.0,10.0,3700.0,1900.0,850.0,120.0,22.0,6000.0,2300.0,700.0,130.0,22.0,10300.0,4340.0,1650.0,265.0,54.0,18.20115607,0.134494536,Intrahepatic Cholestasis,,Liver,Cholestasis,Cholestasis,0.0,50.0,,100ul serum. 0.1M ammonia for pH13 and mixture heated to 64deg for 15min. 1ml Strata-X cartridges conditioned with 50:50 v/v 2-propanol: hexane: methanol and 94.9:5:0.1 v/v/v methanol/water/formic acid. Equilibrate with 1ml water; 1ml sample loaded. Washed with water and water/methanol 95:5. BAs eluted 94.9:5:0.1 methanol/water/formic acid and vacuum evaporated to dryness and reconstituted in 60:40 10mM ammonium formate/methanol.,100.0,Sodium Hydroxide,Vacuum,Ammonium Formate:Methanol,SPE,,HPLC-MS,2009,Median,,HPLC-MS: Median; Intrahepatic Cholestasis,50.0
114,Long-term effects of Roux en-Y gastric bypass on postprandial plasma lipid and bile acids kinetics in female non diabetic subjects: A cross-sectional pilot study.,https://doi.org/10.1016/j.clnu.2014.09.018,Plasma,11,Normal,Fed,GC-MS,uM,30.0,0.0,90.0,10.0,0.0,110.0,640.0,240.0,110.0,10.0,20.0,60.0,30.0,,0.0,160.0,700.0,360.0,120.0,10.0,9.384615385,0.569767442,Obese,,Healthy,Normal,Normal,0.0,11.0,33.4,,,,,,,,GC-MS,2015,Arithmetic Mean,,GC-MS: Mean; Healthy controls; 180 mins after meal ingestion,11.0
115,Long-term effects of Roux en-Y gastric bypass on postprandial plasma lipid and bile acids kinetics in female non diabetic subjects: A cross-sectional pilot study.,https://doi.org/10.1016/j.clnu.2014.09.018,Plasma,11,Unhealthy,Fed,GC-MS,uM,330.0,230.0,320.0,20.0,0.0,650.0,2460.0,1100.0,110.0,10.0,280.0,400.0,210.0,,0.0,1260.0,3090.0,1630.0,130.0,10.0,5.8,0.406896552,,,,,,0.0,11.0,35.1,,,,,,,,GC-MS,2015,Arithmetic Mean,,GC-MS: Mean; RYGB patients; 60 mins after meal ingestion,11.0
116,Long-term effects of Roux en-Y gastric bypass on postprandial plasma lipid and bile acids kinetics in female non diabetic subjects: A cross-sectional pilot study.,https://doi.org/10.1016/j.clnu.2014.09.018,Plasma,11,Normal,Fed,GC-MS,uM,40.0,20.0,90.0,20.0,0.0,80.0,460.0,160.0,60.0,20.0,10.0,40.0,20.0,,0.0,130.0,520.0,270.0,80.0,20.0,5.0,0.569230769,Obese,,Healthy,Normal,Normal,0.0,11.0,33.4,,,,,,,,GC-MS,2015,Arithmetic Mean,,GC-MS: Mean; Healthy controls; 60 mins after meal ingestion,11.0
117,Long-term effects of Roux en-Y gastric bypass on postprandial plasma lipid and bile acids kinetics in female non diabetic subjects: A cross-sectional pilot study.,https://doi.org/10.1016/j.clnu.2014.09.018,Plasma,11,Normal,Fed,GC-MS,uM,370.0,10.0,90.0,20.0,0.0,90.0,630.0,200.0,120.0,10.0,10.0,70.0,30.0,,0.0,470.0,710.0,320.0,140.0,10.0,2.367346939,0.398305085,Obese,,Healthy,Normal,Normal,0.0,11.0,33.4,,,,,,,,GC-MS,2015,Arithmetic Mean,,GC-MS: Mean; Healthy controls; 120 mins after meal ingestion,11.0
118,Long-term effects of Roux en-Y gastric bypass on postprandial plasma lipid and bile acids kinetics in female non diabetic subjects: A cross-sectional pilot study.,https://doi.org/10.1016/j.clnu.2014.09.018,Plasma,11,Unhealthy,Fed,GC-MS,uM,360.0,280.0,380.0,20.0,0.0,140.0,1070.0,360.0,70.0,10.0,20.0,70.0,30.0,,0.0,520.0,1420.0,770.0,90.0,10.0,1.701923077,0.448453608,,,,,,0.0,11.0,35.1,,,,,,,,GC-MS,2015,Arithmetic Mean,,GC-MS: Mean; RYGB patients; 180 mins after meal ingestion,11.0
119,Long-term effects of Roux en-Y gastric bypass on postprandial plasma lipid and bile acids kinetics in female non diabetic subjects: A cross-sectional pilot study.,https://doi.org/10.1016/j.clnu.2014.09.018,Plasma,11,Unhealthy,Fasted,GC-MS,uM,350.0,160.0,260.0,0.0,0.0,140.0,750.0,240.0,70.0,10.0,20.0,30.0,20.0,,0.0,510.0,940.0,520.0,70.0,10.0,1.662337662,0.413793103,,,,,,0.0,11.0,35.1,,,,,,,,GC-MS,2015,Arithmetic Mean,,GC-MS: Mean; RYGB patients; Fasted,11.0
120,Long-term effects of Roux en-Y gastric bypass on postprandial plasma lipid and bile acids kinetics in female non diabetic subjects: A cross-sectional pilot study.,https://doi.org/10.1016/j.clnu.2014.09.018,Plasma,11,Normal,Fasted,GC-MS,uM,60.0,30.0,80.0,20.0,0.0,30.0,140.0,50.0,40.0,0.0,0.0,0.0,0.0,,0.0,90.0,170.0,130.0,60.0,0.0,1.368421053,0.730769231,Obese,,Healthy,Normal,Normal,0.0,11.0,33.4,,,,,,,,GC-MS,2015,Arithmetic Mean,,GC-MS: Mean; Healthy controls; Fasted,11.0
121,Long-term effects of Roux en-Y gastric bypass on postprandial plasma lipid and bile acids kinetics in female non diabetic subjects: A cross-sectional pilot study.,https://doi.org/10.1016/j.clnu.2014.09.018,Plasma,11,Unhealthy,Fed,GC-MS,uM,530.0,350.0,470.0,40.0,0.0,160.0,970.0,360.0,60.0,10.0,30.0,70.0,40.0,,0.0,720.0,1390.0,870.0,100.0,10.0,1.223021583,0.464454976,,,,,,0.0,11.0,35.1,,,,,,,,GC-MS,2015,Arithmetic Mean,0.53,GC-MS: Mean; RYGB patients; 120 mins after meal ingestion,11.0
122,Metabolomic profiling of 17 bile acids in serum from patients with primary biliary cirrhosis and primary sclerosing cholangitis: A pilot study,https://doi.org/10.1016/j.dld.2011.10.025,Serum,12,Unhealthy,Fasted,LC-MS,nM,121.99,216.75,257.49,114.12,15.26,4519.37,6272.49,912.44,,32.66,8356.15,4084.59,164.19,27.21,8.39,12997.51,10573.83,1334.12,,56.31,33.59585728,0.064984002,Primary Biliary Cirrhosis,,Liver,,,0.0,12.0,54.4,100ul serum. 2ml 0.1% formic acid and 30ul internal standard. SPE columns condtioned with 1ml MeOH and 2ml 0.1% formic acid. Column washed with H2O and H2O:MeOH containing 0.1% formic acid. BAs eluted with 2ml MeOH. Evaporated at 45deg under N2 and reconstituted in 100ul H2O:MeOH (50:50) containing 5mM ammonium acetate and 0.01% formic acid. ,100.0,Formic Acid,N2,Methanol:H2O,SPE,,LC-MS/MS,2012,Arithmetic Mean,1.2,LC-MS/MS: Mean; Primary Biliary Cirrhosis,12.0
123,Metabolomic profiling of 17 bile acids in serum from patients with primary biliary cirrhosis and primary sclerosing cholangitis: A pilot study,https://doi.org/10.1016/j.dld.2011.10.025,Serum,6,Unhealthy,Fasted,LC-MS,nM,109.37,152.24,75.42,683.24,5.82,9104.3,6980.7,93.05,,9.68,3813.78,1372.71,28.07,34.67,4.43,13027.45,8505.65,196.54,,19.93,20.89620793,0.04339273,Primary Sclerosing Cholangitis,,Liver,Cholestasis,Cholestasis,5.0,1.0,37.7,100ul serum. 2ml 0.1% formic acid and 30ul internal standard. SPE columns condtioned with 1ml MeOH and 2ml 0.1% formic acid. Column washed with H2O and H2O:MeOH containing 0.1% formic acid. BAs eluted with 2ml MeOH. Evaporated at 45deg under N2 and reconstituted in 100ul H2O:MeOH (50:50) containing 5mM ammonium acetate and 0.01% formic acid. ,100.0,Formic Acid,N2,Methanol:H2O,SPE,,LC-MS/MS,2012,Arithmetic Mean,1.7,LC-MS/MS: Mean; Primary Sclerosing cholangitis,6.0
124,Metabolomic profiling of 17 bile acids in serum from patients with primary biliary cirrhosis and primary sclerosing cholangitis: A pilot study,https://doi.org/10.1016/j.dld.2011.10.025,Serum,30,Normal,Fasted,LC-MS,nM,99.41,176.7,345.43,93.08,16.78,190.2,748.93,296.13,,13.22,183.6,119.21,43.46,5.29,26.36,473.21,1044.84,685.02,,56.36,2.223680613,0.553176773,,,Healthy,Normal,Normal,27.0,3.0,44.2,100ul serum. 2ml 0.1% formic acid and 30ul internal standard. SPE columns condtioned with 1ml MeOH and 2ml 0.1% formic acid. Column washed with H2O and H2O:MeOH containing 0.1% formic acid. BAs eluted with 2ml MeOH. Evaporated at 45deg under N2 and reconstituted in 100ul H2O:MeOH (50:50) containing 5mM ammonium acetate and 0.01% formic acid. ,100.0,Formic Acid,N2,Methanol:H2O,SPE,,LC-MS/MS,2012,Arithmetic Mean,0.49,LC-MS/MS: Mean; Non-cholestatic control B.,30.0
125,Metabolomic profiling of 17 bile acids in serum from patients with primary biliary cirrhosis and primary sclerosing cholangitis: A pilot study,https://doi.org/10.1016/j.dld.2011.10.025,Serum,30,Normal,Fasted,LC-MS,nM,181.54,256.85,386.74,137.6,12.8,233.04,771.49,246.19,,16.28,179.7,120.17,44.91,5.01,23.38,594.28,1148.51,677.84,,52.46,1.681311697,0.500869296,,,Healthy,Normal,Normal,3.0,27.0,52.1,100ul serum. 2ml 0.1% formic acid and 30ul internal standard. SPE columns condtioned with 1ml MeOH and 2ml 0.1% formic acid. Column washed with H2O and H2O:MeOH containing 0.1% formic acid. BAs eluted with 2ml MeOH. Evaporated at 45deg under N2 and reconstituted in 100ul H2O:MeOH (50:50) containing 5mM ammonium acetate and 0.01% formic acid. ,100.0,Formic Acid,N2,Methanol:H2O,SPE,,LC-MS/MS,2012,Arithmetic Mean,0.53,LC-MS/MS: Mean; Non-cholestatic control A.,30.0
126,Metabolomic profiling of bile acids in clinical and experimental samples of Alzheimer’s disease.,https://doi.org/10.3390/metabo7020028,Plasma,10,Unknown,Unknown,LC-MS,nM,156.0,312.2,638.0,101.0,44.0,364.0,1118.0,831.0,170.0,42.0,87.0,184.0,106.0,,,607.0,1614.2,1575.0,,,2.319373402,0.869800108,Alzheimer's Disease,,Healthy,Normal,Normal,4.0,6.0,76.3,Biocrates Bile Acid Kit,,,,,,,UPLC-TQMS,2017,Arithmetic Mean,,UPLC-TQMS: Mean; Alzheimer's Disease; No check for comorbidities,10.0
127,Metabolomic profiling of bile acids in clinical and experimental samples of Alzheimer’s disease.,https://doi.org/10.3390/metabo7020028,Plasma,10,Unknown,Unknown,LC-MS,nM,947.0,2781.0,938.0,206.0,63.0,281.0,1218.0,625.0,141.0,42.0,39.0,147.0,60.0,,,1267.0,4146.0,1623.0,,,0.517325228,0.383336412,,,Healthy,Normal,Normal,5.0,5.0,77.6,Biocrates Bile Acid Kit,,,,,,,UPLC-TQMS,2017,Arithmetic Mean,,UPLC-TQMS: Mean; No Alzheimer's Disease; No check for comorbidities,10.0
128,Middle-distance running acutely influences the concentration and composition of serum bile acids: Potential implications for cancer risk?,https://doi.org/10.18632/oncotarget.17188,Serum,30,Unknown,Fasted,LC-MS,uM,60.0,120.0,100.0,10.0,10.0,150.0,710.0,170.0,60.0,,20.0,140.0,,,,230.0,970.0,,,,4.166666667,0.291666667,,,Healthy,Normal,Normal,21.0,9.0,45.0,500ul serum. 5ul IS. Mixed with 1000ul acetonitrile. Vortex. Centrifuge. SN transferred to autosampler,500.0,Acetonitrile,,,Direct Injection,,UPLC-TQMS,2017,Median,,UPLC-TQMS: Median; Post-exercise; No check for EHC diseases,30.0
129,Middle-distance running acutely influences the concentration and composition of serum bile acids: Potential implications for cancer risk?,https://doi.org/10.18632/oncotarget.17188,Serum,30,Unknown,Fasted,LC-MS,uM,160.0,390.0,320.0,50.0,10.0,200.0,710.0,220.0,60.0,,20.0,90.0,,,,380.0,1190.0,,,,1.397849462,0.420382166,,,Healthy,Normal,Normal,21.0,9.0,45.0,500ul serum. 5ul IS. Mixed with 1000ul acetonitrile. Vortex. Centrifuge. SN transferred to autosampler,500.0,Acetonitrile,,,Direct Injection,,UPLC-TQMS,2017,Median,,UPLC-TQMS: Median; Pre-exercise; No check for EHC diseases,30.0
130,NASH-related increases in plasma bile acid levels depend on insulin resistance,https://doi.org/10.1016/j.jhepr.2020.100222,Plasma,17,Unhealthy,Fasted,LC-MS,nM,205.0,452.0,417.0,91.0,13.0,671.0,1382.0,405.0,138.0,17.0,134.0,224.0,106.0,11.0,3.7,1010.0,2058.0,928.0,240.0,33.7,2.624533107,0.391688396,NASH,,Liver,NASH,Metabolic,5.0,12.0,38.2,50ul serum. 325ul 1/100 dilution IS solution. 225ul cold MeOH added for protein precipitation. Vortex. Kept at -20deg for 20mins; Centrifuge. SN dried in Savant speedvac concentrator. Reconsititute in 50ul MeOH:H20 50:50 v/v. Centrifuge,50.0,Methanol,Vacuum,Methanol:H2O,,,HPLC-MS/MS,2020,Arithmetic Mean,,HPLC-MS/MS: Mean; No-T2D; NASH,17.0
131,NASH-related increases in plasma bile acid levels depend on insulin resistance,https://doi.org/10.1016/j.jhepr.2020.100222,Plasma,58,Unhealthy,Fasted,LC-MS,nM,266.0,608.0,371.0,153.0,14.0,641.0,1497.0,271.0,236.0,11.0,178.0,296.0,75.0,19.0,2.2,1085.0,2401.0,717.0,408.0,27.2,2.284844193,0.330522088,T2D NASH,,Liver,NASH,Metabolic,21.0,37.0,49.3,50ul serum. 325ul 1/100 dilution IS solution. 225ul cold MeOH added for protein precipitation. Vortex. Kept at -20deg for 20mins; Centrifuge. SN dried in Savant speedvac concentrator. Reconsititute in 50ul MeOH:H20 50:50 v/v. Centrifuge,50.0,Methanol,Vacuum,Methanol:H2O,,,HPLC-MS/MS,2020,Arithmetic Mean,,HPLC-MS/MS: Mean; T2D; NASH,58.0
132,NASH-related increases in plasma bile acid levels depend on insulin resistance,https://doi.org/10.1016/j.jhepr.2020.100222,Plasma,85,Normal,Fasted,LC-MS,nM,141.0,245.0,220.0,85.0,9.0,201.0,611.0,154.0,114.0,8.0,54.0,120.0,53.0,10.0,1.6,396.0,976.0,427.0,209.0,18.6,1.895142857,0.477113703,,,Healthy,Normal,Normal,28.0,57.0,38.5,50ul serum. 325ul 1/100 dilution IS solution. 225ul cold MeOH added for protein precipitation. Vortex. Kept at -20deg for 20mins; Centrifuge. SN dried in Savant speedvac concentrator. Reconsititute in 50ul MeOH:H20 50:50 v/v. Centrifuge,50.0,Methanol,Vacuum,Methanol:H2O,,,HPLC-MS/MS,2020,Arithmetic Mean,,HPLC-MS/MS: Mean; No-T2D; No NASH,85.0
133,NASH-related increases in plasma bile acid levels depend on insulin resistance,https://doi.org/10.1016/j.jhepr.2020.100222,Plasma,59,Normal,Fasted,LC-MS,nM,114.0,334.0,258.0,98.0,10.0,150.0,598.0,144.0,103.0,9.0,24.0,72.0,39.0,5.0,1.4,288.0,1004.0,441.0,206.0,20.4,1.407125307,0.516563467,T2D,,Healthy,Normal,Normal,20.0,39.0,47.1,50ul serum. 325ul 1/100 dilution IS solution. 225ul cold MeOH added for protein precipitation. Vortex. Kept at -20deg for 20mins; Centrifuge. SN dried in Savant speedvac concentrator. Reconsititute in 50ul MeOH:H20 50:50 v/v. Centrifuge,50.0,Methanol,Vacuum,Methanol:H2O,,,HPLC-MS/MS,2020,Arithmetic Mean,,HPLC-MS/MS: Mean; T2D; No NASH,59.0
134,Portal venous bile acids in cholesterol gallstone disease: Effect of treatment with chenodeoxycholic and cholic acids.,https://doi.org/10.1002/hep.1840050423,Serum,9,Unhealthy,Fasted,GC-MS,uM,,,,,,,,,,,,,,,,600.0,930.0,750.0,,,,,Adenomyoma of Gallbladder,,Non-Liver,,,1.0,8.0,52.0,1ml serum. Hydrolysis with 1M KOH at 110deg for 12h. Alkaline solution ectracted 3 times with ethyl ether. BAs extracted from acidified water phase with ethyl ether. Methylated with diazomethane and converted into trimethylsilyl ether. LKB 9000 Instrument and 1.5% SE-30 column,1000.0,,,,,,GC-MS,1985,Arithmetic Mean,,GC-MS: Mean;  Adenomyoma of Gallbladder no gallstones,9.0
135,Portal venous bile acids in cholesterol gallstone disease: Effect of treatment with chenodeoxycholic and cholic acids.,https://doi.org/10.1002/hep.1840050423,Serum,20,Unhealthy,Fasted,GC-MS,uM,,,,,,,,,,,,,,,,520.0,1330.0,900.0,,,,,Cholelithiasis,,Non-Liver,,,8.0,12.0,56.0,1ml serum. Hydrolysis with 1M KOH at 110deg for 12h. Alkaline solution ectracted 3 times with ethyl ether. BAs extracted from acidified water phase with ethyl ether. Methylated with diazomethane and converted into trimethylsilyl ether. LKB 9000 Instrument and 1.5% SE-30 column,1000.0,,,,,,GC-MS,1985,Arithmetic Mean,,GC-MS: Mean; Cholelithiasis,20.0
136,Postprandial Plasma Concentrations of Individual Bile Acids and FGF-19 in Patients With Type 2 Diabetes,https://doi.org/10.1210/jc.2016-1607,Plasma,15,Normal,Fasted,LC-MS,uM,60.0,70.0,100.0,0.0,,100.0,280.0,100.0,0.0,,0.0,20.0,0.0,0.0,,130.0,380.0,200.0,30.0,,2.173913043,0.377358491,,,Healthy,Normal,Normal,9.0,6.0,59.7,50ul diluted with IS and 500ul acetonitrile. Centrifuge; dry under N2 and reconstitute in 100ul MeOH:H2O (1:3). Injected in UPLC column. BAs separated using gradient from 98% 5mM ammoniumformate:methanol (3:1) to 98% acetonitrile:H2O (9:1 v:v). Waters Quattro Premier XE  ,50.0,Acetonitrile,N2,Methanol:H2O,,,UPLC-MS/MS,2016,Median,,UPLC-MS/MS: Median; Normal Glucose Tolerant,15.0
137,Postprandial Plasma Concentrations of Individual Bile Acids and FGF-19 in Patients With Type 2 Diabetes,https://doi.org/10.1210/jc.2016-1607,Plasma,15,Normal,Fasted,LC-MS,uM,70.0,70.0,310.0,40.0,,120.0,310.0,170.0,30.0,,30.0,70.0,30.0,0.0,,220.0,450.0,510.0,70.0,,1.551020408,0.865671642,T2D,,,,,9.0,6.0,59.4,50ul diluted with IS and 500ul acetonitrile. Centrifuge; dry under N2 and reconstitute in 100ul MeOH:H2O (1:3). Injected in UPLC column. BAs separated using gradient from 98% 5mM ammoniumformate:methanol (3:1) to 98% acetonitrile:H2O (9:1 v:v). Waters Quattro Premier XE  ,50.0,Acetonitrile,N2,Methanol:H2O,,,UPLC-MS/MS,2016,Median,,UPLC-MS/MS: Median; T2D,15.0
138,Postprandial serum bile acids in healthy man. Evidence for differences in absorptive pattern between individual bile acids.,https://doi.org/10.1136/gut.18.8.606,Serum,5,Normal,Fasted,GC-MS,uM,,,,,,,,,,,,,,,,460.0,1060.0,1220.0,,,,,,,Healthy,Normal,Normal,0.0,5.0,33.0,1ml serum. Hydrolysis with 1M KOH at 110deg for 12h. Alkaline solution ectracted 3 times with ethyl ether. BAs extracted from acidified water phase with ethyl ether. Methylated with diazomethane and converted into trimethylsilyl ether. LKB 9000 Instrument and 1.5% SE-30 column,1000.0,,,,,,GC-MS,1977,Arithmetic Mean,,GC-MS: Mean; Before standardized meal,5.0
139,Postprandial serum bile acids in healthy man. Evidence for differences in absorptive pattern between individual bile acids.,https://doi.org/10.1136/gut.18.8.607,Serum,5,Normal,Fed,GC-MS,uM,,,,,,,,,,,,,,,,560.0,2150.0,1920.0,,,,,,,Healthy,Normal,Normal,0.0,5.0,33.0,1ml serum. Hydrolysis with 1M KOH at 110deg for 12h. Alkaline solution ectracted 3 times with ethyl ether. BAs extracted from acidified water phase with ethyl ether. Methylated with diazomethane and converted into trimethylsilyl ether. LKB 9000 Instrument and 1.5% SE-30 column,1000.0,,,,,,GC-MS,1977,Arithmetic Mean,,GC-MS: Mean; 30 mins after standardized meal,5.0
140,Postprandial serum bile acids in healthy man. Evidence for differences in absorptive pattern between individual bile acids.,https://doi.org/10.1136/gut.18.8.608,Serum,5,Normal,Fed,GC-MS,uM,,,,,,,,,,,,,,,,740.0,2440.0,1910.0,,,,,,,Healthy,Normal,Normal,0.0,5.0,33.0,1ml serum. Hydrolysis with 1M KOH at 110deg for 12h. Alkaline solution ectracted 3 times with ethyl ether. BAs extracted from acidified water phase with ethyl ether. Methylated with diazomethane and converted into trimethylsilyl ether. LKB 9000 Instrument and 1.5% SE-30 column,1000.0,,,,,,GC-MS,1977,Arithmetic Mean,,GC-MS: Mean; 60 mins after standardized meal,5.0
141,Postprandial serum bile acids in healthy man. Evidence for differences in absorptive pattern between individual bile acids.,https://doi.org/10.1136/gut.18.8.609,Serum,5,Normal,Fed,GC-MS,uM,,,,,,,,,,,,,,,,1010.0,3040.0,2240.0,,,,,,,Healthy,Normal,Normal,0.0,5.0,33.0,1ml serum. Hydrolysis with 1M KOH at 110deg for 12h. Alkaline solution ectracted 3 times with ethyl ether. BAs extracted from acidified water phase with ethyl ether. Methylated with diazomethane and converted into trimethylsilyl ether. LKB 9000 Instrument and 1.5% SE-30 column,1000.0,,,,,,GC-MS,1977,Arithmetic Mean,,GC-MS: Mean; 90 mins after standardized meal,5.0
142,Postprandial serum bile acids in healthy man. Evidence for differences in absorptive pattern between individual bile acids.,https://doi.org/10.1136/gut.18.8.610,Serum,5,Normal,Fed,GC-MS,uM,,,,,,,,,,,,,,,,720.0,2410.0,2009.9999999999998,,,,,,,Healthy,Normal,Normal,0.0,5.0,33.0,1ml serum. Hydrolysis with 1M KOH at 110deg for 12h. Alkaline solution ectracted 3 times with ethyl ether. BAs extracted from acidified water phase with ethyl ether. Methylated with diazomethane and converted into trimethylsilyl ether. LKB 9000 Instrument and 1.5% SE-30 column,1000.0,,,,,,GC-MS,1977,Arithmetic Mean,,GC-MS: Mean; 120 mins after standardized meal,5.0
143,Postprandial serum bile acids in healthy man. Evidence for differences in absorptive pattern between individual bile acids.,https://doi.org/10.1136/gut.18.8.611,Serum,5,Normal,Fed,GC-MS,uM,,,,,,,,,,,,,,,,570.0,1800.0,1650.0,,,,,,,Healthy,Normal,Normal,0.0,5.0,33.0,1ml serum. Hydrolysis with 1M KOH at 110deg for 12h. Alkaline solution ectracted 3 times with ethyl ether. BAs extracted from acidified water phase with ethyl ether. Methylated with diazomethane and converted into trimethylsilyl ether. LKB 9000 Instrument and 1.5% SE-30 column,1000.0,,,,,,GC-MS,1977,Arithmetic Mean,,GC-MS: Mean; 150 mins after standardized meal,5.0
144,Postprandial serum concentration of individual bile acids in man. Influence of ileal resection.,https://doi.org/10.3109/00365528209181093,Serum,10,Normal,Fasted,GC-MS,uM,,,,,,,,,,,,,,,,340.0,980.0,,,,,,,,Healthy,Normal,Normal,4.0,6.0,33.0,1ml serum. Hydrolysis with 1M KOH at 110deg for 12h. Alkaline solution ectracted 3 times with ethyl ether. BAs extracted from acidified water phase with ethyl ether. Methylated with diazomethane and converted into trimethylsilyl ether. LKB 9000 Instrument and 1.5% SE-30 column,1000.0,,,,,,GC-MS,1982,Arithmetic Mean,,GC-MS: Mean; Fasting; Healthy Control,10.0
145,Postprandial serum concentration of individual bile acids in man. Influence of ileal resection.,https://doi.org/10.3109/00365528209181093,Serum,10,Normal,Fed,GC-MS,uM,,,,,,,,,,,,,,,,420.0,1240.0,,,,,,,,Healthy,Normal,Normal,4.0,6.0,33.0,1ml serum. Hydrolysis with 1M KOH at 110deg for 12h. Alkaline solution ectracted 3 times with ethyl ether. BAs extracted from acidified water phase with ethyl ether. Methylated with diazomethane and converted into trimethylsilyl ether. LKB 9000 Instrument and 1.5% SE-30 column,1000.0,,,,,,GC-MS,1982,Arithmetic Mean,,GC-MS: Mean; 15 mins after meal; Healthy Control,10.0
146,Postprandial serum concentration of individual bile acids in man. Influence of ileal resection.,https://doi.org/10.3109/00365528209181093,Serum,10,Normal,Fed,GC-MS,uM,,,,,,,,,,,,,,,,470.0,1580.0,,,,,,,,Healthy,Normal,Normal,4.0,6.0,33.0,1ml serum. Hydrolysis with 1M KOH at 110deg for 12h. Alkaline solution ectracted 3 times with ethyl ether. BAs extracted from acidified water phase with ethyl ether. Methylated with diazomethane and converted into trimethylsilyl ether. LKB 9000 Instrument and 1.5% SE-30 column,1000.0,,,,,,GC-MS,1982,Arithmetic Mean,,GC-MS: Mean; 30 mins after meal; Healthy Control,10.0
147,Postprandial serum concentration of individual bile acids in man. Influence of ileal resection.,https://doi.org/10.3109/00365528209181093,Serum,10,Normal,Fed,GC-MS,uM,,,,,,,,,,,,,,,,510.0,1730.0,,,,,,,,Healthy,Normal,Normal,4.0,6.0,33.0,1ml serum. Hydrolysis with 1M KOH at 110deg for 12h. Alkaline solution ectracted 3 times with ethyl ether. BAs extracted from acidified water phase with ethyl ether. Methylated with diazomethane and converted into trimethylsilyl ether. LKB 9000 Instrument and 1.5% SE-30 column,1000.0,,,,,,GC-MS,1982,Arithmetic Mean,,GC-MS: Mean; 45 mins after meal; Healthy Control,10.0
148,Postprandial serum concentration of individual bile acids in man. Influence of ileal resection.,https://doi.org/10.3109/00365528209181093,Serum,10,Normal,Fed,GC-MS,uM,,,,,,,,,,,,,,,,560.0,1880.0,,,,,,,,Healthy,Normal,Normal,4.0,6.0,33.0,1ml serum. Hydrolysis with 1M KOH at 110deg for 12h. Alkaline solution ectracted 3 times with ethyl ether. BAs extracted from acidified water phase with ethyl ether. Methylated with diazomethane and converted into trimethylsilyl ether. LKB 9000 Instrument and 1.5% SE-30 column,1000.0,,,,,,GC-MS,1982,Arithmetic Mean,,GC-MS: Mean; 60 mins after meal; Healthy Control,10.0
149,Postprandial serum concentration of individual bile acids in man. Influence of ileal resection.,https://doi.org/10.3109/00365528209181093,Serum,10,Normal,Fed,GC-MS,uM,,,,,,,,,,,,,,,,660.0,2290.0,,,,,,,,Healthy,Normal,Normal,4.0,6.0,33.0,1ml serum. Hydrolysis with 1M KOH at 110deg for 12h. Alkaline solution ectracted 3 times with ethyl ether. BAs extracted from acidified water phase with ethyl ether. Methylated with diazomethane and converted into trimethylsilyl ether. LKB 9000 Instrument and 1.5% SE-30 column,1000.0,,,,,,GC-MS,1982,Arithmetic Mean,,GC-MS: Mean; 75 mins after meal; Healthy Control,10.0
150,Postprandial serum concentration of individual bile acids in man. Influence of ileal resection.,https://doi.org/10.3109/00365528209181093,Serum,10,Normal,Fed,GC-MS,uM,,,,,,,,,,,,,,,,770.0,2640.0,,,,,,,,Healthy,Normal,Normal,4.0,6.0,33.0,1ml serum. Hydrolysis with 1M KOH at 110deg for 12h. Alkaline solution ectracted 3 times with ethyl ether. BAs extracted from acidified water phase with ethyl ether. Methylated with diazomethane and converted into trimethylsilyl ether. LKB 9000 Instrument and 1.5% SE-30 column,1000.0,,,,,,GC-MS,1982,Arithmetic Mean,,GC-MS: Mean; 90 mins after meal; Healthy Control,10.0
151,Postprandial serum concentration of individual bile acids in man. Influence of ileal resection.,https://doi.org/10.3109/00365528209181093,Serum,10,Normal,Fed,GC-MS,uM,,,,,,,,,,,,,,,,690.0,2410.0,,,,,,,,Healthy,Normal,Normal,4.0,6.0,33.0,1ml serum. Hydrolysis with 1M KOH at 110deg for 12h. Alkaline solution ectracted 3 times with ethyl ether. BAs extracted from acidified water phase with ethyl ether. Methylated with diazomethane and converted into trimethylsilyl ether. LKB 9000 Instrument and 1.5% SE-30 column,1000.0,,,,,,GC-MS,1982,Arithmetic Mean,,GC-MS: Mean; 105 mins after meal; Healthy Control,10.0
152,Postprandial serum concentration of individual bile acids in man. Influence of ileal resection.,https://doi.org/10.3109/00365528209181093,Serum,10,Normal,Fed,GC-MS,uM,,,,,,,,,,,,,,,,620.0,2040.0,,,,,,,,Healthy,Normal,Normal,4.0,6.0,33.0,1ml serum. Hydrolysis with 1M KOH at 110deg for 12h. Alkaline solution ectracted 3 times with ethyl ether. BAs extracted from acidified water phase with ethyl ether. Methylated with diazomethane and converted into trimethylsilyl ether. LKB 9000 Instrument and 1.5% SE-30 column,1000.0,,,,,,GC-MS,1982,Arithmetic Mean,,GC-MS: Mean; 120 mins after meal; Healthy Control,10.0
153,Postprandial serum concentration of individual bile acids in man. Influence of ileal resection.,https://doi.org/10.3109/00365528209181093,Serum,10,Normal,Fed,GC-MS,uM,,,,,,,,,,,,,,,,600.0,1860.0,,,,,,,,Healthy,Normal,Normal,4.0,6.0,33.0,1ml serum. Hydrolysis with 1M KOH at 110deg for 12h. Alkaline solution ectracted 3 times with ethyl ether. BAs extracted from acidified water phase with ethyl ether. Methylated with diazomethane and converted into trimethylsilyl ether. LKB 9000 Instrument and 1.5% SE-30 column,1000.0,,,,,,GC-MS,1982,Arithmetic Mean,,GC-MS: Mean; 135 mins after meal; Healthy Control,10.0
154,Postprandial serum concentration of individual bile acids in man. Influence of ileal resection.,https://doi.org/10.3109/00365528209181093,Serum,10,Normal,Fed,GC-MS,uM,,,,,,,,,,,,,,,,570.0,1690.0,,,,,,,,Healthy,Normal,Normal,4.0,6.0,33.0,1ml serum. Hydrolysis with 1M KOH at 110deg for 12h. Alkaline solution ectracted 3 times with ethyl ether. BAs extracted from acidified water phase with ethyl ether. Methylated with diazomethane and converted into trimethylsilyl ether. LKB 9000 Instrument and 1.5% SE-30 column,1000.0,,,,,,GC-MS,1982,Arithmetic Mean,,GC-MS: Mean; 150 mins after meal; Healthy Control,10.0
155,Postprandial serum concentration of individual bile acids in man. Influence of ileal resection.,https://doi.org/10.3109/00365528209181093,Serum,7,Unhealthy,Fasted,GC-MS,uM,,,,,,,,,,,,,,,,620.0,1250.0,,,,,,Ileal Resection,,Non-Liver,,,3.0,4.0,35.0,1ml serum. Hydrolysis with 1M KOH at 110deg for 12h. Alkaline solution ectracted 3 times with ethyl ether. BAs extracted from acidified water phase with ethyl ether. Methylated with diazomethane and converted into trimethylsilyl ether. LKB 9000 Instrument and 1.5% SE-30 column,1000.0,,,,,,GC-MS,1982,Arithmetic Mean,,GC-MS: Mean; Fasting; Ileal resectioned patients,7.0
156,Postprandial serum concentration of individual bile acids in man. Influence of ileal resection.,https://doi.org/10.3109/00365528209181093,Serum,7,Unhealthy,Fed,GC-MS,uM,,,,,,,,,,,,,,,,920.0,1750.0,,,,,,Ileal Resection,,Non-Liver,,,3.0,4.0,35.0,1ml serum. Hydrolysis with 1M KOH at 110deg for 12h. Alkaline solution ectracted 3 times with ethyl ether. BAs extracted from acidified water phase with ethyl ether. Methylated with diazomethane and converted into trimethylsilyl ether. LKB 9000 Instrument and 1.5% SE-30 column,1000.0,,,,,,GC-MS,1982,Arithmetic Mean,,GC-MS: Mean; 30 mins after meal; Ileal resectioned patients,7.0
157,Postprandial serum concentration of individual bile acids in man. Influence of ileal resection.,https://doi.org/10.3109/00365528209181093,Serum,7,Unhealthy,Fed,GC-MS,uM,,,,,,,,,,,,,,,,580.0,1620.0,,,,,,Ileal Resection,,Non-Liver,,,3.0,4.0,35.0,1ml serum. Hydrolysis with 1M KOH at 110deg for 12h. Alkaline solution ectracted 3 times with ethyl ether. BAs extracted from acidified water phase with ethyl ether. Methylated with diazomethane and converted into trimethylsilyl ether. LKB 9000 Instrument and 1.5% SE-30 column,1000.0,,,,,,GC-MS,1982,Arithmetic Mean,,GC-MS: Mean; 60 mins after meal; Ileal resectioned patients,7.0
158,Postprandial serum concentration of individual bile acids in man. Influence of ileal resection.,https://doi.org/10.3109/00365528209181093,Serum,7,Unhealthy,Fed,GC-MS,uM,,,,,,,,,,,,,,,,670.0,1930.0,,,,,,Ileal Resection,,Non-Liver,,,3.0,4.0,35.0,1ml serum. Hydrolysis with 1M KOH at 110deg for 12h. Alkaline solution ectracted 3 times with ethyl ether. BAs extracted from acidified water phase with ethyl ether. Methylated with diazomethane and converted into trimethylsilyl ether. LKB 9000 Instrument and 1.5% SE-30 column,1000.0,,,,,,GC-MS,1982,Arithmetic Mean,,GC-MS: Mean; 90 mins after meal; Ileal resectioned patients,7.0
159,Postprandial serum concentration of individual bile acids in man. Influence of ileal resection.,https://doi.org/10.3109/00365528209181093,Serum,7,Unhealthy,Fed,GC-MS,uM,,,,,,,,,,,,,,,,670.0,1950.0,,,,,,Ileal Resection,,Non-Liver,,,3.0,4.0,35.0,1ml serum. Hydrolysis with 1M KOH at 110deg for 12h. Alkaline solution ectracted 3 times with ethyl ether. BAs extracted from acidified water phase with ethyl ether. Methylated with diazomethane and converted into trimethylsilyl ether. LKB 9000 Instrument and 1.5% SE-30 column,1000.0,,,,,,GC-MS,1982,Arithmetic Mean,,GC-MS: Mean; 120 mins after meal; Ileal resectioned patients,7.0
160,Postprandial serum concentration of individual bile acids in man. Influence of ileal resection.,https://doi.org/10.3109/00365528209181093,Serum,7,Unhealthy,Fed,GC-MS,uM,,,,,,,,,,,,,,,,610.0,1720.0,,,,,,Ileal Resection,,Non-Liver,,,3.0,4.0,35.0,1ml serum. Hydrolysis with 1M KOH at 110deg for 12h. Alkaline solution ectracted 3 times with ethyl ether. BAs extracted from acidified water phase with ethyl ether. Methylated with diazomethane and converted into trimethylsilyl ether. LKB 9000 Instrument and 1.5% SE-30 column,1000.0,,,,,,GC-MS,1982,Arithmetic Mean,,GC-MS: Mean; 150 mins after meal; Ileal resectioned patients,7.0
161,Prediagnostic alterations in circulating bile acid profiles in the development of hepatocellular carcinoma,https://doi.org/10.1002/ijc.33885,Plasma,233,Unhealthy,Both,LC-MS,nM,116.8,262.2,308.3,35.5,,496.7,1687.5,315.7,147.3,27.8,246.7,63.7,2.8,14.0,,860.2,2013.4,626.8,196.8,27.8,4.153569452,0.296283408,Hepatocellular Carcinoma,,Liver,HCC,HCC,153.0,80.0,59.1,50ul plasma. 325ul 1/100 dilution IS solution. 225ul cold MeOH added for protein precipitation. Vortex. Kept at -20deg for 20mins; Centrifuge. SN dried in Savant speedvac concentrator. Reconsititute in 50ul MeOH:H20 50:50 v/v. Centrifuge,50.0,Methanol,Vacuum,Methanol:H2O,,,LC-MS/MS,2021,Arithmetic Mean,0.63,LC-MS/MS: Mean; Hepatocellular Carcinoma (includes patients with Hep B/C),233.0
162,Prediagnostic alterations in circulating bile acid profiles in the development of hepatocellular carcinoma,https://doi.org/10.1002/ijc.33885,Plasma,233,Both,Both,LC-MS,nM,75.4,161.1,256.6,23.0,,173.6,804.0,194.7,74.3,17.4,65.7,24.4,1.2,3.9,,314.7,989.5,452.5,101.2,,2.63359814,0.437892961,,,Healthy,Normal,Normal,153.0,80.0,59.1,50ul plasma. 325ul 1/100 dilution IS solution. 225ul cold MeOH added for protein precipitation. Vortex. Kept at -20deg for 20mins; Centrifuge. SN dried in Savant speedvac concentrator. Reconsititute in 50ul MeOH:H20 50:50 v/v. Centrifuge,50.0,Methanol,Vacuum,Methanol:H2O,,,LC-MS/MS,2021,Arithmetic Mean,0.5,LC-MS/MS: Mean; Non hepatoceullar carcinoma matched control but (includes patients with Hep B/C),233.0
163,Prediagnostic Concentrations of Circulating Bile Acids and Hepatocellular Carcinoma Risk: REVEAL-HBV and HCV Studies,https://doi.org/10.1002/ijc.33051,Serum,185,Unhealthy,Unknown,LC-MS,nM,214.71,372.02,163.8,72.65,9.12,866.53,1804.57,364.77,205.02,10.73,271.44,617.91,96.37,25.2,7.2,1352.68,2794.5,624.94,302.87,27.05,5.130049261,0.230243201,Hepatocellular Carcinoma,,Liver,HCC,HCC,150.0,35.0,51.3,,,,,,,,LC-MS/MS,2020,Arithmetic Mean,,LC-MS/MS: Mean; HBV Positive with HCC (some patients with cirrhosis at baseline),185.0
164,Prediagnostic Concentrations of Circulating Bile Acids and Hepatocellular Carcinoma Risk: REVEAL-HBV and HCV Studies,https://doi.org/10.1002/ijc.33051,Serum,96,Unhealthy,Unknown,LC-MS,nM,221.28,347.43,179.49,69.9,12.27,800.21,1396.41,292.83,152.53,14.96,357.58,458.4,82.58,20.39,7.46,1379.07,2202.24,554.9,242.82,34.69,4.31536544,0.232431708,Hepatocellular Carcinoma,,Liver,HCC,HCC,56.0,40.0,54.4,,,,,,,,LC-MS/MS,2020,Arithmetic Mean,,LC-MS/MS: Mean; HCV Positive with HCC (some patients with cirrhosis at baseline),96.0
165,Prediagnostic Concentrations of Circulating Bile Acids and Hepatocellular Carcinoma Risk: REVEAL-HBV and HCV Studies,https://doi.org/10.1002/ijc.33051,Serum,161,Unhealthy,Unknown,LC-MS,nM,150.84,319.62,195.43,68.73,8.92,429.73,1052.47,313.82,144.4,13.17,111.08,239.4,76.09,14.13,7.0,691.65,1611.49,585.34,227.26,29.09,3.229537079,0.365453251,Hep B,,Liver,,,130.0,31.0,50.7,,,,,,,,LC-MS/MS,2020,Arithmetic Mean,,LC-MS/MS: Mean; HBV Positive  Controls ,161.0
166,Prediagnostic Concentrations of Circulating Bile Acids and Hepatocellular Carcinoma Risk: REVEAL-HBV and HCV Studies,https://doi.org/10.1002/ijc.33051,Serum,96,Unhealthy,Unknown,LC-MS,nM,202.01,346.06,178.53,86.35,9.93,232.18,727.37,173.39,138.94,10.3,89.4,191.06,54.26,16.47,7.21,523.59,1264.49,406.18,241.76,27.44,1.993705036,0.377712407,Hep C,,Liver,,,56.0,40.0,54.5,,,,,,,,LC-MS/MS,2020,Arithmetic Mean,,LC-MS/MS: Mean; HCV Positive Controls (some patients with cirrhosis at baseline),96.0
167,Prediagnostic Plasma Bile Acid Levels and Colon Cancer Risk: A Prospective Study,https://doi.org/10.1093/jnci/djz166,Plasma,569,Unknown,Both,LC-MS,nM,76.5,150.4,217.5,23.1,,94.9,462.9,107.2,59.1,10.1,12.9,45.0,14.5,2.5,,184.3,658.3,339.2,84.7,,1.730695187,0.515072395,,,,,,213.0,356.0,57.5,50ul spiked with IS. Proteins precipitated. Samples dried and reconstituted in 50ul MeOH:H2O 50:50.,50.0,Methanol,Vacuum,Methanol:H2O,,,UPLC-MRM-MS,2019,Median,,UPLC-MRM-MS: Median; Matched Control (Unknown EHC diseases),569.0
168,Prediagnostic Plasma Bile Acid Levels and Colon Cancer Risk: A Prospective Study,https://doi.org/10.1093/jnci/djz166,Plasma,569,Unhealthy,Both,LC-MS,nM,91.7,164.3,239.3,22.9,,119.8,496.8,125.3,55.5,9.6,15.0,50.5,17.0,2.5,,226.5,711.6,381.6,80.9,,1.721343111,0.503251253,Primary Colon Cancer,,Non-Liver,,,213.0,356.0,57.5,50ul spiked with IS. Proteins precipitated. Samples dried and reconstituted in 50ul MeOH:H2O 50:50.,50.0,Methanol,Vacuum,Methanol:H2O,,,UPLC-MRM-MS,2019,Median,,UPLC-MRM-MS: Median; Primary Colon Cancer,569.0
169,Primary bile acids as potential biomarkers for the clinical grading of intrahepatic cholestasis of pregnancy,https://doi.org/10.1016/j.ijgo.2013.02.015,Serum,33,Unhealthy,Fed,LC-MS,uM,820.0,190.0,370.0,120.0,60.0,16950.0,7120.0,2070.0,,120.0,24250.0,3010.0,1300.0,190.0,90.0,42020.0,10320.0,3740.0,310.0,270.0,35.32051282,0.082537256,Severe Intrahepatic Cholestasis,,Liver,Cholestasis,Cholestasis,0.0,33.0,29.4,300ul serum mixed with 1ml 0.05% formic acid. Loaded onto reversed-phase extraction cartridges conditioned with 1ml MeOH and 1ml 0.05% formic acid. Cartridges washed with 1ml 0.05% formic acid and 1ml 45% MeOH. BAs eluted from cartridge with 1.5ml MeOH and dried under N2 at 60degs. Reconstitute in in 100ul 20% methanol 0.01% formic acid with ultrasonication.,300.0,Formic Acid,N2,,SPE,,HPLC-MS/MS,2013,Arithmetic Mean,,HPLC-MS/MS: Mean; Severe intrahepatic cholestasis of pregnancy; 7 patients with TBIL or DBIL>1.46mg/dl,33.0
170,Primary bile acids as potential biomarkers for the clinical grading of intrahepatic cholestasis of pregnancy,https://doi.org/10.1016/j.ijgo.2013.02.015,Serum,28,Unhealthy,Fed,LC-MS,uM,370.0,250.0,520.0,140.0,60.0,4050.0,3020.0,2000.0,,120.0,3330.0,1050.0,320.0,140.0,100.0,7750.0,4320.0,2840.0,280.0,280.0,10.54477612,0.281690141,Mild Intrahepatic Cholestasis,,Liver,Cholestasis,Cholestasis,0.0,28.0,27.9,300ul serum mixed with 1ml 0.05% formic acid. Loaded onto reversed-phase extraction cartridges conditioned with 1ml MeOH and 1ml 0.05% formic acid. Cartridges washed with 1ml 0.05% formic acid and 1ml 45% MeOH. BAs eluted from cartridge with 1.5ml MeOH and dried under N2 at 60degs. Reconstitute in in 100ul 20% methanol 0.01% formic acid with ultrasonication.,300.0,Formic Acid,N2,,SPE,,HPLC-MS/MS,2013,Arithmetic Mean,,HPLC-MS/MS: Mean; Mild intrahepatic cholestasis of pregnancy; No patients with TBIL or DBIL>1.46mg/dl,28.0
171,Primary bile acids as potential biomarkers for the clinical grading of intrahepatic cholestasis of pregnancy,https://doi.org/10.1016/j.ijgo.2013.02.015,Serum,35,Normal,Fasted,LC-MS,uM,350.0,470.0,500.0,190.0,60.0,1470.0,1610.0,920.0,,120.0,440.0,970.0,110.0,110.0,120.0,2260.0,3050.0,1530.0,300.0,300.0,3.738853503,0.401129944,,,Healthy,Normal,Normal,0.0,35.0,28.7,300ul serum mixed with 1ml 0.05% formic acid. Loaded onto reversed-phase extraction cartridges conditioned with 1ml MeOH and 1ml 0.05% formic acid. Cartridges washed with 1ml 0.05% formic acid and 1ml 45% MeOH. BAs eluted from cartridge with 1.5ml MeOH and dried under N2 at 60degs. Reconstitute in in 100ul 20% methanol 0.01% formic acid with ultrasonication.,300.0,Formic Acid,N2,,SPE,,HPLC-MS/MS,2013,Arithmetic Mean,,HPLC-MS/MS: Mean; Normal Pregnancy; No patients with TBIL>1.46mg/dl,35.0
172,Profiling Circulating and Urinary Bile Acids in Patients with Biliary Obstruction before and after Biliary Stenting,https://doi.org/10.1371/journal.pone.0022094,Serum,17,Unhealthy,Fasted,LC-MS,nM,173.3,84.4,20.7,20.3,1.5,56222.3,28534.5,417.6,,10.5,54486.9,16577.8,213.4,74.9,11.6,110882.5,45196.7,651.7,,23.6,521.4840107,0.004936596,Biliary Stenosis,,Liver,Cholestasis,Cholestasis,8.0,9.0,64.0,100ul serum. 2ml 0.1% formic acid and 30ul internal standard. SPE columns condtioned with 1ml MeOH and 2ml 0.1% formic acid. Column washed with H2O and H2O:MeOH containing 0.1% formic acid. BAs eluted with 2ml MeOH. Evaporated at 45deg under N2 and recons,100.0,Formic Acid,N2,Methanol:H2O;Ammonium Acetate;Formic Acid,SPE,,HPLC-MS/MS,2011,Arithmetic Mean,1.6,HPLC-MS/MS: Mean; Post-stenting,17.0
173,Profiling Circulating and Urinary Bile Acids in Patients with Biliary Obstruction before and after Biliary Stenting,https://doi.org/10.1371/journal.pone.0022094,Serum,17,Unhealthy,Fasted,LC-MS,nM,86.6,236.2,254.4,1085.6,26.3,460.4,1986.8,225.9,,46.7,302.6,286.7,43.2,97.6,13.8,849.6,2509.7,523.5,,86.8,2.050618673,0.533890989,Biliary Stenosis,,Liver,Cholestasis,Cholestasis,8.0,9.0,64.0,100ul serum. 2ml 0.1% formic acid and 30ul internal standard. SPE columns condtioned with 1ml MeOH and 2ml 0.1% formic acid. Column washed with H2O and H2O:MeOH containing 0.1% formic acid. BAs eluted with 2ml MeOH. Evaporated at 45deg under N2 and recons,100.0,Formic Acid,N2,Methanol:H2O;Ammonium Acetate;Formic Acid,SPE,,HPLC-MS/MS,2011,Arithmetic Mean,15.06,HPLC-MS/MS: Mean; Pre-stenting,17.0
174,Profiling Circulating and Urinary Bile Acids in Patients with Biliary Obstruction before and after Biliary Stenting,https://doi.org/10.1371/journal.pone.0022094,Serum,40,Normal,Fasted,LC-MS,nM,181.5,256.8,386.7,137.6,12.8,233.0,771.5,246.2,,16.3,179.7,120.2,44.9,5.0,23.4,594.2,1148.5,677.8,,52.5,1.681566537,0.500889424,,,Healthy,Normal,Normal,20.0,20.0,,100ul serum. 2ml 0.1% formic acid and 30ul internal standard. SPE columns condtioned with 1ml MeOH and 2ml 0.1% formic acid. Column washed with H2O and H2O:MeOH containing 0.1% formic acid. BAs eluted with 2ml MeOH. Evaporated at 45deg under N2 and recons,100.0,Formic Acid,N2,Methanol:H2O;Ammonium Acetate;Formic Acid,SPE,,HPLC-MS/MS,2011,Arithmetic Mean,0.54,HPLC-MS/MS: Mean; Non-cholestatic patients,40.0
175,Profiling of Serum Bile Acids in a Healthy Chinese Population Using UPLC–MS/MS,https://doi.org/10.1021/pr500920q,Serum,138,Normal,Fasted,LC-MS,ng/ml,79.9314733235438,214.8751910341314,177.53438614365766,74.52878247580234,7.620817843866171,156.42182130584192,451.51245551601426,120.24021352313169,32.895907473309606,6.5728782287822884,20.18615474112856,31.658995397238346,18.91134680808485,3.6621973183910352,3.7626628075253254,115.9,303.18,133.21,45.88,7.54,1.767694768,0.445332633,,,Healthy,Normal,Normal,0.0,138.0,,50ul serum. 150ul MeOH with IS. Vortex. Stand for 10min. Centrifuge. 160ul SN vacuum-dried. Reconstituted in equal volumes acetonitrile H2O. ,50.0,Methanol,Vacuum,Acetonitrile:H2O,,,UPLC-MS/MS,2015,Arithmetic Mean,,UPLC-MS/MS: Mean; Healthy females,138.0
176,Profiling of Serum Bile Acids in a Healthy Chinese Population Using UPLC–MS/MS,https://doi.org/10.1021/pr500920q,Serum,364,Normal,Fasted,LC-MS,ng/ml,124.37591776798824,365.4610290371879,156.74987264391237,106.59704533876719,7.010090281465747,175.536941580756,625.7339857651245,95.57384341637011,52.246441281138786,3.9437269372693726,14.834205933682373,36.96217730638383,13.608164898939364,4.102461476886131,3.3285094066570187,140.2,443.28,111.31,67.39,5.96,1.557653248,0.316480428,,,Healthy,Normal,Normal,364.0,0.0,,50ul serum. 150ul MeOH with IS. Vortex. Stand for 10min. Centrifuge. 160ul SN vacuum-dried. Reconstituted in equal volumes acetonitrile H2O. ,50.0,Methanol,Vacuum,Acetonitrile:H2O,,,UPLC-MS/MS,2015,Arithmetic Mean,,UPLC-MS/MS: Mean; Healthy males,364.0
177,Quantitation of serum bile acids by isotope dilution with 13C labelled homologs.,https://doi.org/10.1016/0009-8981(87)90231-2,Serum,15,Normal,Fasted,GC-MS,uM,,,,,,,,,,,,,,,,490.0,980.0,1070.0,,,,,,,Healthy,Normal,Normal,7.0,8.0,,Reversed phase octadecylsilane bonded silica cartridges; solvolysed; hydrolysed enzymatically; reextracted on Lipidex 100 and derivatised to methyl ester TMS ether derivatives. Separated on fused silica capillary GLC column coated with OV-1701 and introduced to Finnigan 4000 MS,,,,,,,GC-MS,1987,Arithmetic Mean,,GC-MS: Mean; Healthy; Fasted,15.0
178,Quantitation of serum bile acids by isotope dilution with 13C labelled homologs.,https://doi.org/10.1016/0009-8981(87)90231-2,Serum,15,Normal,Fed,GC-MS,uM,,,,,,,,,,,,,,,,810.0,2420.0,1660.0,,,,,,,Healthy,Normal,Normal,7.0,8.0,,Reversed phase octadecylsilane bonded silica cartridges; solvolysed; hydrolysed enzymatically; reextracted on Lipidex 100 and derivatised to methyl ester TMS ether derivatives. Separated on fused silica capillary GLC column coated with OV-1701 and introduced to Finnigan 4000 MS,,,,,,,GC-MS,1987,Arithmetic Mean,,GC-MS: Mean; Healthy; Fed (2h after standard meal),15.0
179,Quantitative Analysis of Bile Acids in Human Plasma by Liquid Chromatography-Electrospray Tandem Mass Spectrometry: A Simple and Rapid One-Step Method,https://doi.org/10.1515/CCLM.2003.247,Plasma,7,Unhealthy,Unknown,LC-MS,uM,1161.0,771.0,140.0,343.0,21.0,31971.0,17714.0,1963.0,,180.0,14443.0,5968.0,576.0,1614.0,31.0,47575.0,24453.0,2679.0,,232.0,30.56650246,0.067584828,Cholestatic Hepatobiliary Disease,,Liver,Cholestasis,Cholestasis,,,,250ul plasma mixed with 800ul acetonitrile. Vortex and centrifuge. SN blown to dryness with N2. Reconstituted in 125ul methanol and 125ul water.,250.0,Acetonitrile,N2,Methanol:H2O,,,LC-MS/MS,2011,Arithmetic Mean,,LC-MS/MS: Mean; Cholestatic,
180,Quantitative Analysis of Bile Acids in Human Plasma by Liquid Chromatography-Electrospray Tandem Mass Spectrometry: A Simple and Rapid One-Step Method,https://doi.org/10.1515/CCLM.2003.247,Plasma,10,Normal,Unknown,LC-MS,uM,111.0,200.0,129.0,118.0,10.0,232.0,696.0,83.0,,6.0,70.0,228.0,19.0,8.0,0.6,413.0,1124.0,231.0,,16.6,2.363732394,0.243070917,,,Healthy,Normal,Normal,,,,250ul plasma mixed with 800ul acetonitrile. Vortex and centrifuge. SN blown to dryness with N2. Reconstituted in 125ul methanol and 125ul water.,250.0,Acetonitrile,N2,Methanol:H2O,,,LC-MS/MS,2011,Arithmetic Mean,,LC-MS/MS: Mean; clinical controls,
181,Quantitative bile acid profiling by liquid chromatography quadrupole time-of-flight mass spectrometry: monitoring hepatitis B therapy by a novel Na+ -taurocholate cotransporting polypeptide inhibitor,https://doi.org/10.1007/s00216-015-8853-5,Plasma,10,Normal,Fed,LC-MS,nM,220.0,224.0,284.0,138.0,,315.0,1321.0,435.0,204.0,78.0,49.0,144.0,61.0,15.0,24.0,584.0,1689.0,780.0,357.0,102.0,3.055427252,0.545094589,,,Healthy,Normal,Normal,5.0,5.0,33.5,50ul plasma. Add 210ul ice-cold MeOH and 20ul MeOH/H2O 1:1 with IS to reach 300nM concentration. Vortex. Incubate 20mins at -20degs. Centrifuge. Evaporate SN under N2 at 40degs. Reconstitute in 100ul 12 mM ammonium acetate in water and centrifuge.,50.0,Methanol,N2,Ammonium Acetate:Water,,,UPLC-MS,2015,Arithmetic Mean,,UPLC-MS: Mean; Healthy; Plasma,10.0
182,Quantitative bile acid profiling by liquid chromatography quadrupole time-of-flight mass spectrometry: monitoring hepatitis B therapy by a novel Na+ -taurocholate cotransporting polypeptide inhibitor,https://doi.org/10.1007/s00216-015-8853-5,Serum,9,Normal,Fed,LC-MS,nM,283.0,227.0,304.0,55.0,,270.0,871.0,425.0,133.0,21.0,132.0,198.0,113.0,11.0,12.0,685.0,1296.0,842.0,199.0,33.0,2.515535098,0.542150429,,,Healthy,Normal,Normal,4.0,5.0,37.5,50ul plasma. Add 210ul ice-cold MeOH and 20ul MeOH/H2O 1:1 with IS to reach 300nM concentration. Vortex. Incubate 20mins at -20degs. Centrifuge. Evaporate SN under N2 at 40degs. Reconstitute in 100ul 12 mM ammonium acetate in water and centrifuge.,50.0,Methanol,N2,Ammonium Acetate:Water,,,UPLC-MS,2015,Arithmetic Mean,,UPLC-MS; Mean; Healthy; Serum,9.0
183,Ratio of Conjugated Chenodeoxycholic to Muricholic Acids is Associated with Severity of Nonalcoholic Steatohepatitis,https://doi.org/10.1002/oby.22627,Serum,48,Unhealthy,Fasted,LC-MS,nM,15.91,61.23,28.61,15.88,0.29,61.48,224.11,17.82,34.75,0.35,10.09,24.4,3.43,15.88,0.5,87.48,309.74,49.86,66.51,1.14,3.221866798,0.295831026,NASH,,Liver,NASH,Metabolic,30.0,18.0,41.17,50ul serum. 150ul MeOH with IS. Vortex. Stand for 10min. Centrifuge. 160ul SN vacuum-dried. Reconstituted in equal volumes acetonitrile H2O. ,50.0,Methanol,Vacuum,Acetonitrile:H2O,,,UPLC-TQMS,2019,Arithmetic Mean,0.9,UPLC-TQMS: Mean; NASH (Validation Cohort); NAS >4,48.0
184,Ratio of Conjugated Chenodeoxycholic to Muricholic Acids is Associated with Severity of Nonalcoholic Steatohepatitis,https://doi.org/10.1002/oby.22627,Serum,48,Unhealthy,Fasted,LC-MS,nM,23.67,138.99,46.22,28.78,0.48,81.52,288.82,39.25,56.38,1.37,11.81,35.29,7.96,2.13,0.0,117.0,463.1,93.43,87.29,1.85,2.202611909,0.3147216,NASH,,Liver,NASH,Metabolic,30.0,18.0,41.17,50ul serum. 150ul MeOH with IS. Vortex. Stand for 10min. Centrifuge. 160ul SN vacuum-dried. Reconstituted in equal volumes acetonitrile H2O. ,50.0,Methanol,Vacuum,Acetonitrile:H2O,,,UPLC-TQMS,2019,Arithmetic Mean,0.87,UPLC-TQMS: Mean; NASH (Training Cohort); NAS>4,48.0
185,Ratio of Conjugated Chenodeoxycholic to Muricholic Acids is Associated with Severity of Nonalcoholic Steatohepatitis,https://doi.org/10.1002/oby.22627,Serum,24,Unhealthy,Fasted,LC-MS,nM,14.37,55.61,11.47,29.08,0.06,25.44,112.32,2.12,31.76,0.04,2.78,11.34,1.12,29.08,0.49,42.59,179.27,14.71,89.92,0.59,1.957591102,0.474263049,NAFL,,Liver,NAFL,Metabolic,16.0,8.0,46.71,50ul serum. 150ul MeOH with IS. Vortex. Stand for 10min. Centrifuge. 160ul SN vacuum-dried. Reconstituted in equal volumes acetonitrile H2O. ,50.0,Methanol,Vacuum,Acetonitrile:H2O,,,UPLC-TQMS,2019,Arithmetic Mean,0.7,UPLC-TQMS: Mean;  Non-NASH (Validation Cohort),24.0
186,Ratio of Conjugated Chenodeoxycholic to Muricholic Acids is Associated with Severity of Nonalcoholic Steatohepatitis,https://doi.org/10.1002/oby.22627,Serum,24,Unhealthy,Fasted,LC-MS,nM,58.94,185.29,49.51,54.95,0.46,93.69,418.22,25.79,67.52,0.43,8.14,42.22,3.08,2.17,0.0,160.77,645.73,78.38,124.64,0.89,1.893913791,0.25283323,NAFL,,Liver,NAFL,Metabolic,16.0,8.0,46.71,50ul serum. 150ul MeOH with IS. Vortex. Stand for 10min. Centrifuge. 160ul SN vacuum-dried. Reconstituted in equal volumes acetonitrile H2O. ,50.0,Methanol,Vacuum,Acetonitrile:H2O,,,UPLC-TQMS,2019,Arithmetic Mean,1.08,UPLC-TQMS: Mean;  Non-NASH (Training Cohort),24.0
187,Ratio of Conjugated Chenodeoxycholic to Muricholic Acids is Associated with Severity of Nonalcoholic Steatohepatitis,https://doi.org/10.1002/oby.22627,Serum,15,Normal,Fasted,LC-MS,nM,18.32,90.14,84.97,19.04,0.77,21.97,159.77,30.69,19.77,1.74,2.42,9.7,3.77,0.96,0.0,42.71,259.61,119.43,39.77,2.51,1.176092666,0.534896798,,,Healthy,Normal,Normal,9.0,6.0,40.4,50ul serum. 150ul MeOH with IS. Vortex. Stand for 10min. Centrifuge. 160ul SN vacuum-dried. Reconstituted in equal volumes acetonitrile H2O. ,50.0,Methanol,Vacuum,Acetonitrile:H2O,,,UPLC-TQMS,2019,Arithmetic Mean,0.92,UPLC-TQMS: Mean; Healthy Control (Training Cohort),15.0
188,Sensitivity and Specificity of Biochemical Tests for Diagnosis of Intrahepatic Cholestasis of Pregnancy,https://doi.org/10.5604/01.3001.0010.0294,Serum,29,Normal,Fasted,GLC,uM,,,,,,,,,,,,,,,,2000.0,2000.0,2000.0,0.0,0.0,,,,,Healthy,Normal,Normal,0.0,29.0,28.1,"2ml serum diluted with 8ml 0.1M NaOH. BAs extracted by absorption on 100mg Bond Elut octadecylsilane bonded silica cartridge. Wash cartridge with 5ml 0.1M NaOH and 5ml H2O. BAs eluted with 6ml 75% MeOH. Interfering substances were then removed by extraction with 6ml n-hexane after acidification of eluate to pH 3-4. Dried with N2 at 60deg.  After neutralization and evapo-
ration of the solvent; the glycine and taurine conjugates
were hydrolyzed enzymatically for 2 hr at 37°C using
cholylglycine hydrolase (18). After acidification to pH
3-4; the aqueous solution was passed through a 4 X 1
cm Lipidex 1000 column prepared according to Setchell
and Matsui (15). Thereafter; the column was washed
with 15 ml of 0.01 N HCI and 20 ml of water and the
deconjugated bile acids were eluted with 10 ml of 75%
methanol. The solvent was evaporated under nitrogen
at 60°C. The methylation of the bile acids was carried
out according to Ali and Javitt (19) using 2;2dimethoxy-
propane and the trimethylsilyl ethers were formed with
pyridine-hexamethyldisilane-trimethylchlorosilane 3:2: 1
(v/v) at 60°C under nitrogen for 15 min (15). The
sample was taken to dryness and dissolved in 25-50 pl
of isooctane for healthy subjects and in up to 500 ~1 for
patients with liver disease. ",2000.0,,,,,,GLC,2017,Median,0.7,GLC: Median; Healthy pregnant women,29.0
189,Sensitivity and Specificity of Biochemical Tests for Diagnosis of Intrahepatic Cholestasis of Pregnancy,https://doi.org/10.5604/01.3001.0010.0294,Serum,61,Unhealthy,Fasted,GLC,uM,,,,,,,,,,,,,,,,14000.0,13000.0,3000.0,1000.0,1000.0,,,Intrahepatic Cholestasis,,Liver,Cholestasis,Cholestasis,0.0,61.0,28.59,"2ml serum diluted with 8ml 0.1M NaOH. BAs extracted by absorption on 100mg Bond Elut octadecylsilane bonded silica cartridge. Wash cartridge with 5ml 0.1M NaOH and 5ml H2O. BAs eluted with 6ml 75% MeOH. Interfering substances were then removed by extraction with 6ml n-hexane after acidification of eluate to pH 3-4. Dried with N2 at 60deg.  After neutralization and evapo-
ration of the solvent; the glycine and taurine conjugates
were hydrolyzed enzymatically for 2 hr at 37°C using
cholylglycine hydrolase (18). After acidification to pH
3-4; the aqueous solution was passed through a 4 X 1
cm Lipidex 1000 column prepared according to Setchell
and Matsui (15). Thereafter; the column was washed
with 15 ml of 0.01 N HCI and 20 ml of water and the
deconjugated bile acids were eluted with 10 ml of 75%
methanol. The solvent was evaporated under nitrogen
at 60°C. The methylation of the bile acids was carried
out according to Ali and Javitt (19) using 2;2dimethoxy-
propane and the trimethylsilyl ethers were formed with
pyridine-hexamethyldisilane-trimethylchlorosilane 3:2: 1
(v/v) at 60°C under nitrogen for 15 min (15). The
sample was taken to dryness and dissolved in 25-50 pl
of isooctane for healthy subjects and in up to 500 ~1 for
patients with liver disease. ",2000.0,,,,,,GLC,2017,Median,0.7,GLC: Median; Intrahepatic cholestasis of pregnancy,61.0
190,Sequential changes in serum levels of individual bile acids in patients with chronic cholestatic liver disease,https://doi.org/10.1111/j.1440-1746.1996.tb00064.x,Serum,5,Normal,Fasted,HPLC,uM,970.0,1020.0,,,,,,,,,,,,,,,3300.0,,,,,,,,Healthy,Normal,Normal,5.0,0.0,,,,,,,,,HPLC,1990,Arithmetic Mean,,HPLC: Mean; Healthy Controls,5.0
191,Sequential changes in serum levels of individual bile acids in patients with chronic cholestatic liver disease,https://doi.org/10.1111/j.1440-1746.1996.tb00064.x,Serum,12,Unhealthy,Fasted,HPLC,uM,520.0,370.0,,,,,,,,,,,,,,,13000.0,,,,,,Primary Biliary Cirrhosis,,Liver,,,1.0,11.0,56.4,,,,,,,,HPLC,1990,Arithmetic Mean,1.17,HPLC: Mean; Primary Biliary Cirrhosis 1st Visit,12.0
192,Sequential changes in serum levels of individual bile acids in patients with chronic cholestatic liver disease,https://doi.org/10.1111/j.1440-1746.1996.tb00064.x,Serum,12,Unhealthy,Fasted,HPLC,uM,80.0,290.0,,,,,,,,,,,,,,,35000.0,,,,,,Primary Biliary Cirrhosis,,Liver,,,1.0,11.0,56.4,,,,,,,,HPLC,1990,Arithmetic Mean,2.57,HPLC: Mean; Primary Biliary Cirrhosis 2nd Visit,12.0
193,Sequential changes in serum levels of individual bile acids in patients with chronic cholestatic liver disease,https://doi.org/10.1111/j.1440-1746.1996.tb00064.x,Serum,6,Unhealthy,Fasted,HPLC,uM,340.0,180.0,,,,,,,,,,,,,,,18000.0,,,,,,Primary Sclerosing cholangitis,,Liver,Cholestasis,Cholestasis,1.0,5.0,42.7,,,,,,,,HPLC,1990,Arithmetic Mean,0.64,HPLC: Mean; Primary sclerosing cholangitis 1st visit,6.0
194,Sequential changes in serum levels of individual bile acids in patients with chronic cholestatic liver disease,https://doi.org/10.1111/j.1440-1746.1996.tb00064.x,Serum,6,Unhealthy,Fasted,HPLC,uM,50.0,360.0,,,,,,,,,,,,,,,13000.0,,,,,,Primary Sclerosing cholangitis,,Liver,Cholestasis,Cholestasis,1.0,5.0,42.7,,,,,,,,HPLC,1990,Arithmetic Mean,1.75,HPLC: Mean; Primary sclerosing cholangitis 1st visit,6.0
195,Serum Bile Acid Levels in Children With Nonalcoholic Fatty Liver Disease,https://doi.org/10.1097/MPG.0000000000000774,Serum,105,Normal,Fasted,LC-MS,uM,140.0,280.0,260.0,70.0,,550.0,1250.0,310.0,240.0,,60.0,200.0,50.0,30.0,,750.0,1730.0,620.0,340.0,,3.586666667,0.387096774,,,Healthy,Normal,Normal,48.0,57.0,16.0,Reversed phased C18 column using MeOH/H2O gradient,,,,,,,HPLC-MS/MS,2015,Arithmetic Mean,0.6,HPLC-MS/MS: Mean; Controls; Children,105.0
196,Serum Bile Acid Levels in Children With Nonalcoholic Fatty Liver Disease,https://doi.org/10.1097/MPG.0000000000000774,Serum,65,Unhealthy,Fasted,LC-MS,uM,160.0,330.0,230.0,130.0,,330.0,830.0,130.0,170.0,,50.0,130.0,20.0,0.0,,540.0,1290.0,380.0,300.0,,1.952941176,0.371584699,NAFLD,,Liver,NAFLD,Metabolic,,,12.0,Reversed phased C18 column using MeOH/H2O gradient,,,,,,,HPLC-MS/MS,2015,Arithmetic Mean,0.5,HPLC-MS/MS: Mean; NAFLD-F>1; Children,
197,Serum Bile Acid Levels in Children With Nonalcoholic Fatty Liver Disease,https://doi.org/10.1097/MPG.0000000000000774,Serum,27,Unhealthy,Fasted,LC-MS,uM,110.0,280.0,280.0,220.0,,150.0,380.0,70.0,160.0,,50.0,40.0,10.0,0.0,,310.0,700.0,360.0,380.0,,0.966292135,0.732673267,NAFLD,,Liver,NAFLD,Metabolic,,,10.0,Reversed phased C18 column using MeOH/H2O gradient,,,,,,,HPLC-MS/MS,2015,Arithmetic Mean,0.7,HPLC-MS/MS: Mean; NAFLD-F0; Children,
198,Serum Bile Acid Profiles Improve Clinical Prediction of Nonalcoholic Fatty Liver in T2DM patients,https://doi.org/10.1021/acs.jproteome.1c00104,Serum,20,Normal,Fasted,LC-MS,nM,25.65,50.55,185.6,42.1,2.15,28.2,181.35,118.55,34.6,3.75,4.25,20.75,14.4,0.9,0.6,58.1,252.65,318.55,77.6,6.5,1.330991668,1.295736122,T2D No NAFL,,Healthy,Normal,Normal,18.0,2.0,70.5,50ul serum. 325ul 1/100 dilution IS solution. 225ul cold MeOH added for protein precipitation. Vortex. Kept at -20deg for 20mins; Centrifuge. SN dried in Savant speedvac concentrator. Reconsititute in 50ul MeOH:H20 50:50 v/v. Centrifuge,50.0,Methanol,Vacuum,Methanol:H2O,,,UPLC-TQMS,2021,Arithmetic Mean,,UPLC-TQMS: T2D without NAFL (Validation),20.0
199,Serum Bile Acid Profiles Improve Clinical Prediction of Nonalcoholic Fatty Liver in T2DM patients,https://doi.org/10.1021/acs.jproteome.1c00104,Serum,30,Unhealthy,Fasted,LC-MS,nM,79.15,363.85,314.75,153.95,7.8,70.6,447.55,145.4,92.3,2.9,20.6,117.6,24.4,4.55,3.4,170.35,929.0,484.55,250.8,14.1,1.010657966,0.681721017,T2D NAFL,,Liver,NAFL,Metabolic,25.0,5.0,71.5,50ul serum. 325ul 1/100 dilution IS solution. 225ul cold MeOH added for protein precipitation. Vortex. Kept at -20deg for 20mins; Centrifuge. SN dried in Savant speedvac concentrator. Reconsititute in 50ul MeOH:H20 50:50 v/v. Centrifuge,50.0,Methanol,Vacuum,Methanol:H2O,,,UPLC-TQMS,2021,Arithmetic Mean,,UPLC-TQMS:Mean; T2DM with NAFL (Exploration),30.0
200,Serum Bile Acid Profiles Improve Clinical Prediction of Nonalcoholic Fatty Liver in T2DM patients,https://doi.org/10.1021/acs.jproteome.1c00104,Serum,17,Unhealthy,Fasted,LC-MS,nM,73.4,304.9,104.0,271.6,4.1,52.7,332.3,22.3,95.3,0.0,18.7,75.0,5.0,3.4,3.1,144.8,712.2,131.3,370.3,7.2,0.801846966,0.59369895,T2D NAFL,,Liver,NAFL,Metabolic,12.0,5.0,75.0,50ul serum. 325ul 1/100 dilution IS solution. 225ul cold MeOH added for protein precipitation. Vortex. Kept at -20deg for 20mins; Centrifuge. SN dried in Savant speedvac concentrator. Reconsititute in 50ul MeOH:H20 50:50 v/v. Centrifuge,50.0,Methanol,Vacuum,Methanol:H2O,,,UPLC-TQMS,2021,Arithmetic Mean,,UPLC-TQMS: Mean; T2DM with NAFL (Validation),17.0
201,Serum Bile Acid Profiles Improve Clinical Prediction of Nonalcoholic Fatty Liver in T2DM patients,https://doi.org/10.1021/acs.jproteome.1c00104,Serum,36,Normal,Fasted,LC-MS,nM,128.85,374.65,193.55,100.4,0.25,47.6,351.65,74.15,51.4,2.2,7.8,56.85,6.7,1.8,0.6,184.25,783.15,274.4,153.6,3.05,0.75310267,0.44557577,T2D No NAFL,,Healthy,Normal,Normal,24.0,12.0,67.0,50ul serum. 325ul 1/100 dilution IS solution. 225ul cold MeOH added for protein precipitation. Vortex. Kept at -20deg for 20mins; Centrifuge. SN dried in Savant speedvac concentrator. Reconsititute in 50ul MeOH:H20 50:50 v/v. Centrifuge,50.0,Methanol,Vacuum,Methanol:H2O,,,UPLC-TQMS,2021,Arithmetic Mean,,UPLC-TQMS: Mean; T2DM without NAFL (Exploration),36.0
202,Serum bile acids and cholestasis in alcoholic hepatitis. Relationship with usual liver tests and histological features,https://doi.org/10.1016/S0168-8278(05)80401-5,Serum,36,Unhealthy,Fasted,HPLC,uM,,,,,,,,,,,,,,,,8900.0,27500.0,1150.0,,0.0,,,Alcoholic Hepatitis,,Liver,,,17.0,19.0,51.0,,,,,,,,HPLC,1994,Median,2.57,HPLC: Median; Biopsy provven alcohol hepatitis,36.0
203,Serum concentrations of ursodeoxycholic acid in portal venous and systemic venous blood of fasting humans as determined by isotope dilution-mass spectrometry.,https://doi.org/10.1016/S0016-5085(85)80144-X,Serum,9,Normal,Fasted,GC-MS,uM,,,,,,,,,,,,,,,,240.0,790.0,810.0,190.0,,,,,,Healthy,Normal,Normal,,,,0.5ml serum; acetone; hydrolysis with potassium hydroxide. Dilute with saline and extracted twice with ether.  Acidification with HCl. Evaporated and methylated with diazomethane.,500.0,,,,,,GC-MS,1985,Arithmetic Mean,,GC-MS: Mean; Healthy subjects,
204,Serum concentrations of ursodeoxycholic acid in portal venous and systemic venous blood of fasting humans as determined by isotope dilution-mass spectrometry.,https://doi.org/10.1016/S0016-5085(85)80144-X,Serum,7,Unhealthy,Fasted,GC-MS,uM,,,,,,,,,,,,,,,,670.0,1270.0,860.0,240.0,,,,Cholelithiasis,,Non-Liver,,,1.0,6.0,51.0,0.5ml serum; acetone; hydrolysis with potassium hydroxide. Dilute with saline and extracted twice with ether.  Acidification with HCl. Evaporated and methylated with diazomethane.,500.0,,,,,,GC-MS,1985,Arithmetic Mean,,GC-MS: Mean; Gallstone patients,7.0
205,Suppressed hepatic bile acid signalling despite elevated production of primary and secondary bile acids in NAFLD,https://doi.org/10.1136/gutjnl-2017-314307,Serum,11,Normal,Fed,LC-MS,uM,,,,,,,,,,,,,,,,191.0,473.0,155.0,36.4,,,,,,Healthy,Normal,Normal,6.0,5.0,12.8,,,,,,,,LC-MS/MS,2017,Arithmetic Mean,,LC-MS/MS: Mean; Healthy Control; Children,11.0
206,Suppressed hepatic bile acid signalling despite elevated production of primary and secondary bile acids in NAFLD,https://doi.org/10.1136/gutjnl-2017-314307,Serum,16,Unhealthy,Fed,LC-MS,uM,,,,,,,,,,,,,,,,587.0,1580.0,432.0,175.0,,,0.280110752,NASH,,Liver,NASH,Metabolic,9.0,7.0,13.7,,,,,,,,LC-MS/MS,2017,Arithmetic Mean,,LC-MS/MS: Mean; NASH (Kleiner's Criteria); Children,16.0
207,Targeted profiling of circulating and hepatic bile acids in human; mouse; and rat using a  UPLC-MRM-MS-validated method,https://doi.org/10.1194/jlr.D028803,Serum,8,Normal,Unknown,LC-MS,nM,440.0,380.0,320.0,43.0,,85.0,450.0,104.0,76.0,17.0,14.0,69.0,21.0,2.7,0.33,539.0,899.0,445.0,121.7,,0.709239222,0.406140473,,,Healthy,Normal,Normal,,,,50ul serum. 325ul 1/100 dilution IS solution. 225ul cold MeOH added for protein precipitation. Vortex. Kept at -20deg for 20mins; Centrifuge. SN dried in Savant speedvac concentrator. Reconsititute in 50ul MeOH:H20 50:50 v/v. Centrifuge,50.0,Methanol,Vacuum,Methanol:H2O,,,LC-MS/MS,2012,Arithmetic Mean,,LC-MS/MS: Mean; Healthy,
208,The presence and severity of nonalcoholic steatohepatitis is associated with specific changes in circulating bile acids,https://doi.org/10.1002/hep.29359,Plasma,37,Unhealthy,Fasted,LC-MS,uM,48.800000000000004,33.099999999999994,77.60000000000001,,,84.8,65.3,51.0,,,89.39999999999999,78.0,599.0,,,223.0,176.4,727.6,,,6.065830721,1.821732599,NASH,,Liver,NASH,Metabolic,8.0,29.0,58.0,100ul plasma. Protein precipitation with MeOH spiked with IS using automated MicroLab Star. Aliquoted and dried under N2. Reconstituted in acidic (H20:MeOH containing 0.1% formic acid) and basic (H2O:MeOH containing 6.5mM ammonium bicarbonate),100.0,Methanol,N2,Methanol:H2O,,,UPLC-MS,2017,Median,,UPLC-MS: Median; NASH (NASH Clinical Research Network Criteria),37.0
209,The presence and severity of nonalcoholic steatohepatitis is associated with specific changes in circulating bile acids,https://doi.org/10.1002/hep.29359,Plasma,25,Unhealthy,Fasted,LC-MS,uM,54.300000000000004,39.6,39.1,,,59.7,50.7,52.900000000000006,,,53.8,38.6,36.4,,,167.8,128.89999999999998,128.39999999999998,,,2.196240602,0.432760364,NAFL,,Liver,NAFL,Metabolic,10.0,15.0,54.6,100ul plasma. Protein precipitation with MeOH spiked with IS using automated MicroLab Star. Aliquoted and dried under N2. Reconstituted in acidic (H20:MeOH containing 0.1% formic acid) and basic (H2O:MeOH containing 6.5mM ammonium bicarbonate),100.0,Methanol,N2,Methanol:H2O,,,UPLC-MS,2017,Median,,UPLC-MS: Median; NAFL (NASH Clinical Research Network Criteria),25.0
210,The presence and severity of nonalcoholic steatohepatitis is associated with specific changes in circulating bile acids,https://doi.org/10.1002/hep.29359,Plasma,24,Normal,Fasted,LC-MS,uM,50.3,50.1,25.5,,,33.8,37.8,42.2,,,16.1,26.1,35.9,,,100.2,114.0,103.6,,,1.524225576,0.483660131,,,Healthy,Normal,Normal,11.0,13.0,39.2,100ul plasma. Protein precipitation with MeOH spiked with IS using automated MicroLab Star. Aliquoted and dried under N2. Reconstituted in acidic (H20:MeOH containing 0.1% formic acid) and basic (H2O:MeOH containing 6.5mM ammonium bicarbonate),100.0,Methanol,N2,Methanol:H2O,,,UPLC-MS,2017,Median,,UPLC-MS: Median; Healthy controls,24.0
211,The profile of bile acids and their sulfate metabolites in human urine and serum. ,https://doi.org/10.1016/j.jchromb.2013.10.019,Serum,90,Normal,Fasted,LC-MS,nM,193.7,191.9,395.0,77.3,7.5,322.7,580.3,283.1,106.1,,126.9,223.6,79.3,6.18,,643.3,995.8,757.4,189.58,7.5,1.996972498,0.582319566,,,Healthy,Normal,Normal,27.0,63.0,,100ul serum spiked with 10ul IS; 1ml ice-cold  alkaline CAN (5% NH4OH) added. Vortex & Centrifuge. Evaporate SN under vacuum and reconstitute in 100ul 50% MeOH. ,100.0,Acetonitrile,Vacuum,Methanol:H2O,,,UPLC-MS/MS,2013,Arithmetic Mean,,UPLC-MS/MS: Mean; Healthy,90.0
212,Transhepatic bile acid kinetics in pigs and humans,https://doi.org/10.1016/j.clnu.2017.06.015,Plasma,11,Normal,Fasted,LC-MS,uM,60.0,140.0,310.0,,20.0,60.0,290.0,90.0,100.0,30.0,20.0,30.0,,,20.0,140.0,460.0,,,70.0,1.20754717,0.95,Elective Gastric Bypass Surgery,,Healthy,Normal,Normal,1.0,11.0,46.0,25ul plasma. 250ul internal standard. Centrifuge. SN evaporated under N2 at 40deg. Reconstitute in 100ul 50% MeOH H2O,25.0,Trichloroacetic Acid,N2,Methanol:H2O,,,LC-MS/MS,2017,Arithmetic Mean,,LC-MS/MS: Mean; Healthy non-diabetic patients,12.0
213,Unconjugated secondary bile acids in the serum of patients with colorectal adenomas.,https://doi.org/10.1136/gut.36.2.268,Serum,10,Normal,Fasted,GLC,uM,390.0,410.0,320.0,160.0,170.0,,,,,,,,,,,760.0,1340.0,950.0,400.0,420.0,,0.8125,,,Healthy,Normal,Normal,10.0,0.0,,2ml serum extracted on Bond Elut C18 cartridges. BAs eluted with 6ml 75% methanol. Eluate cleaned with n-hexane after pH3.5 acidification. Solvents removed under nitrogen and reconstituted in HCl:Acetone (1:10) for 3h. BAs deconjugated at pH5.9 for 16h. Passed through Lipidex-1000 and eluted with 75% MeOH. BAs methylated and trimethylsilylated. Solvents removed under nitrogen and dissolved in isooctane. ,2000.0,,,,,,Capillary Gas Chromatography,1995,Arithmetic Mean,,Capillary Gas Chromatography: Mean; Healhty controls,10.0
214,Unconjugated secondary bile acids in the serum of patients with colorectal adenomas.,https://doi.org/10.1136/gut.36.2.268,Serum,10,Unhealthy,Fasted,GLC,uM,470.0,510.0,470.0,160.0,210.0,,,,,,,,,,,950.0,1860.0,1890.0,400.0,490.0,,0.857142857,Colorectal Adenoma,,Non-Liver,,,10.0,0.0,,2ml serum extracted on Bond Elut C18 cartridges. BAs eluted with 6ml 75% methanol. Eluate cleaned with n-hexane after pH3.5 acidification. Solvents removed under nitrogen and reconstituted in HCl:Acetone (1:10) for 3h. BAs deconjugated at pH5.9 for 16h. Passed through Lipidex-1000 and eluted with 75% MeOH. BAs methylated and trimethylsilylated. Solvents removed under nitrogen and dissolved in isooctane. ,2000.0,,,,,,Capillary Gas Chromatography,1995,Arithmetic Mean,,Capillary Gas Chromatography: Mean; Colorectal adenoma,10.0
